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Three-dimensional (3D) printing of human tissues and organ has been an exciting research topic in the
past three decades. However, existing technological and biological challenges still require a signiﬁcant
amount of research. The present review highlights these challenges and discusses their potential solu-
tions such as mapping and converting a human organ onto a 3D virtual design, synchronizing the virtual
design with the printing hardware. Moreover, the paper discusses in details recent advances in formu-
lating bio-inks and challenges in tissue construction with or without scaffold. Next, the paper reviews
fusion processes effecting vascular cells and tissues. Finally, the paper deliberates the feasibility of organ
printing with state-of-the-art technologies.
© 2016 The Authors. Publishing services by Elsevier B.V. on behalf of Vietnam National University, Hanoi.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
The invention of the printing press changed the course of hu-
man history. The disruptive technology of printing text and images
impacted society globally, acting as media for education, religion,
politics, language, and culture [1]. Since then, a number of in-
novations further enhanced the printing technologies. For example,
the introduction of dot matrix printers revolutionized the con-
sumer market, where a computer linked to a printer as its pe-
ripheral device allowed desktop publishing and on-demand
printing, reducing cost and time. The advent of the Internet intro-
duced further an advancement, which allows documents to be
available anywhere and printed just by the click of the mouse.
Personalised printing made education, scientiﬁc research and arts
more accessible to the broad population. Table 1 lists the major
milestones in the history of printing technology. Although Charles
Hull ﬁrst introduced in the late 1980 three-dimensional (3D)
printing through the so-called stereo lithography technology, its
signiﬁcance only started to materialise at the turn of the 21st
century [2,3]. This versatile printing technology allows the fabri-
cation of a wide range of 3D objects, from electric components to(N.-T. Nguyen).
onal University, Hanoi.
y Elsevier B.V. on behalf of Vietnambiological implants, through layer-by-layer patterning with ultra-
violet (UV) exposure of photoresist ﬁlms [4].
A 3D printer can also dispense biological materials making bio-
printing possible. Generally, bio-printing can be achieved with
layer-by-layer positioning of biomaterials as well as living cells. The
precise spatial control of the functional materials allows for the
fabrication of 3D tissue structures such as skin, cartilage, tendon,
cardiac muscle, and bone. The process starts with the selection of
the corresponding cells for the tissue [5]. Next, a viable bio-ink
material is prepared from a suitable cell carrier and media.
Finally, the cells are printed for subsequent culture into the
required dimensions. The several approaches of 3D bio-printing are
biomimicry, autonomous self-assembly and mini-tissue building
blocks [6]. In contrast to conventional 3D printing, 3D bio-printing
is more complex in terms of the selection of materials, cell types,
growth/differentiation factors, and sensitivity of the living cells
construction.
A typical 3D bio-printing process consists of the pre-processing,
processing and post-processing stages. Pre-processing consists of
the formation of an organ blueprint from a clinical bio-imaging
system (i.e. MRI) and the conversion of this information into a
direct instruction software of the standard template library (STL)
for the printing hardware, which includes but is not limited to a
series of integrated tools such as automated robotic tools, 3D
positioning systems with printing head, ink reservoir, nozzleNational University, Hanoi. This is an open access article under the CC BY license
Table 1
Major milestones of the history of printing technology.
Milestone Year (CE) Details
Book printing 200 Woodblock printing used in China.
1040 Letters rearranged for each page in movable typing.
1440 Printing press introduced by Johannes Gutenberg.
1884 Introduction of hot metal type setting.
1907 George C. Beidler invented the Photostat machine.
Desktop printing 1968 Dot matrix printing invented by Digital Equipment Corporation.
1970 Inkjet printing produced by Epson, Hewlett-Packard, Cannon.
1979 Laser printer developed by HP for desktop.
3D printing 1984 3D printing invented by Charles Hull called stereo-lithography.
1991 Word's ﬁrst fused deposition modelling (FDM) invented by stratasys that uses plastic and an extruder to make 3D model.
1992 Selective laser sintering machine (SLS) invented by DTM using power with laser to print the 3D model.
2000 3D ink jet printer and multi-colour printer produced. Following year, desktop 3D printer introduced.
2009 Commercial 3D printer available to market.
Fig. 1. Schematic of a 3D positioning system incorporating a print head and printing
bed system.
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trollers, piezo electric humidiﬁers, and integrated controlling
software.
The processing stage is the actual printing session of the bio-ink
using the bio-printers. The processing stage includes bio-ink
preparation, clinical cell sorters (e.g. Celution, Cytori therapeu-
tics), cell propagation bioreactors (e.g. AastromBioscience), and cell
differentiators to construct the desired biological structures.
The post-processing stage comprises the necessary procedures
to transform the printed construct into a functional tissue engi-
neered organ, suitable for surgical implantations. The post-
processing stage may also include perfusion bioreactors, cell
encapsulators and a set of bio-monitoring systems [7]. Each of these
auxiliary machines has their own important roles for scaling up
bio-printing. For example, cell encapsulators and bioreactors are
essential to restrict undesirable fusion processes after the con-
struction. Mironov et al. proposed a bio-reactor that is believed to
maintain fragile tissue construct with sufﬁcient time for post pro-
cessing of tissue fusion, maturation and remodelling [8].
2. Technological considerations
The main technological challenges of 3D bio-printing are (i) the
3D positioning process, (ii) the formulation of a bio-ink and (iii) the
dispensing system.
2.1. Three-dimensional positioning
Precise positioning of the print head plays a crucial role for the
additive layer-by-layer construction of a 3D object. The positioning
system is sometimes referred to as the bio-assembly tool (BAT) that
utilizes computer aided design/manufacturing (CAD/CAM) soft-
ware to precisely deposit various 3D heterogeneous cells [9]. BAT
generally consists of multiple printing heads that can travel in a XY
plane and adding through the Z axis for the printed layer [10]. A
number of sensors are necessary to detect the thickness of each
printed layer, and to adjust the print head for the next layer. Control
software allows for the synchronization of these printing heads in
the 3D space. The softwaremay also consist of a number of text ﬁles
or scripts for organizing the movement of the BAT and controlling
the speed, air pressure as well as temperature. The 3D platform
should be able to stop at various points during the printing process
to change the bio-ink if necessary. Fig. 1 illustrates a typical 3D
positioning system incorporating a print head and a printing bed.
For mapping a human organ, an X-ray, magnetic resonance
imaging (MRI) or computed tomography (CT) scan can be converted
to a bio-computer aided design (Bio-CAD) [11,12]. Surgical naviga-
tion software such as Stryker (Kalamazoo, United States), MedCAD(Dallas, United states) are some of the commercially available Bio-
CAD packages. The Bio-CAD software visualizes 3D anatomic
structures, differentiates heterogeneous tissue types, measures and
differentiates vascular and nerve tissues and generates the desired
computational tissue model [13]. A specialized software such as
Rhinoceros 4.0 (real time simulation integrated with MATLAB/
Simulink) can modify this bio-CAD design in extremely detailed
slices with contour boundary paths that then can be synchronized
with the 3D positioning system [13e16]. The software consists of a
console and amaster. The console analyses the 3Dmodel, renders it
onto a series of commands to be sent to the positioning stage. The
master controls the positioning coordinates of the print head.
Surface mapping observes the printing status of each layer and
decides the time to begin the construction of the next layer. The
waiting time may vary from material to material, depending on its
concentration and its thickness. For instance, Song et al. utilized a
prototype system consisting of stepper motors for each X, Y, and Z
axis movement and another axis for dispensing materials with a
syringe. The positioning system had a precision of approximately
0.05 mm along the X and Y axis and of 0.125 mm in the Z axis. The
optimum speed for depositing the material is typically between 1
and 10 mm/s. The software transferred the CAD model to a layered
process path in Extensible Markup Language (XML) that directly
controls the positioning system [17].
One of the most common problems of additive printing is the
accumulation of errors that is associated with the printing height.
This problem poses a big challenge to the construction of a large
number of layers [18]. The accumulative errors eventually lead to
an unsuccessful attempt for the 3D construct. However, for better
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individual controllable video cameras attached. Furthermore,
ﬁberoptic light sources will illuminate and cure the constructed
layer. A controlled heaters and piezoelectric humidiﬁers can pre-
vent the polymerization in each head. Biomaterials such as collagen
and pluronic-F127 can be easily constructed for a ﬁnite number of
layers but will eventually lose shape due to swelling or dissolution
[19,20]. Specialized techniques incorporating other bio-degradable
materials may solve this problem.
Surface mapping feedback (SMF) is an algorithm-based geo-
metric feedback software that can ﬁnd errors between the printed
layers. The software compares the measurement of the constructed
cell with the virtual CAD model. Accounting for the errors detected
by a displacement sensor, the deposited parameter can then be
adjusted for in subsequent layers [21].
The BAT reported by Smith et al. has a resolution of around 5 mm,
a linear speed between 10 mm/s to 50 mm/s and a deposition rate
between 12 nl/s to 1 ml/s [10]. Smith's group developed a script to
construct a ﬁve-layer artery branch of a pig heart using bovine
aortic endothelial cells (BAECs) suspended in type 1 collagen.
Cohen et al. improved upon a custom built robotic platform for
solid-free fabrication of alginate hydrogel and calcium sulphate to
construct pre-seeded living implants of arbitrary geometries [19].
The robotic platform has XeY axes with a maximum transverse
speed of 50 mm/s. The Z-stage served as a building surface with a
positioning precision of 25 mm. Keating et al. used a 6 axis robotic
arm (KUKA KR5 sixx R850) that limits the deposition of support
material by building a rotating platform for printing complex
structures [22]. The ﬁrst 3 axes are used to position the robotic arm
and the last 3 axes move the platform. The robotic arm used KUKA
robot language and Python scripts to control the movement of the
axes.
2.2. Bio-ink
Bio-ink developments are one of the most challenging issues in
the 3D bio-printing process. Generally, the ink must fulﬁl the bio-
logical, physical and mechanical requirements of the printing
process. Firstly, from a biological aspect, the ink should be
biocompatible whilst allowing cell adhesion and proliferation.
Physically, the ink requires a viscosity low enough to dispense from
the print head. Finally, the paramountmechanical requirement is to
provide sufﬁcient strength and stiffness to maintain structural
integrity of the ink after printing. Bio-inks are composed of living
cells (typically 10,000e30,000 cells per a 10e20 mL droplet) sus-
pended in a medium or pre-gel solution by polymer cross linkers
(such as thrombin, CaCl2, gelatin, ﬁbrinogen, NaCl) that are acti-
vated by photo or thermal processes. For instance, poly (L-lactic
acid) and poly (D, L- Lactic acid) can be dissolved in dioxane, with
bone morphogenic protein grounded into particles and suspended
in deionized water which can be used for making bone scaffold
material [23].
Bio-inks without living cells are generally used to form scaffold
support for later cell culture and growth. Typical scaffold materials
include hydrogels such as agarose, alginate, chitosan, ﬁbrin, gelatin,
poly(ethylene glycol)-PEG hydrogels, poloxamers and poly(2-
hydroxyethyl methacrylate)-pHEMA [24e28]. Besides forming the
scaffold, these materials also help to culture functionalize cells. For
example, agarose is a natural polymer that forms a gel at room
temperature. Lowmelting point at 37 revert the gel into a solution
allowing it to be washed away [29,30]. Alginate is a linear copol-
ymer found in the walls of brown algae. Crosslinking with CaCl2 at
high concentration and low temperature, alginate can rabidly form
a gel with high viscosity [29]. Chitosan is another linear poly-
saccharide obtained from shrimp and crustacean shells.Crosslinking with NaOH allows chitosan to rapidly form a gel ma-
trix [29]. Collagen is a natural protein found in the body, as one of
the materials in cartilage and bone tissues [29,31]. Fibrin is a pro-
tein produced in human body after the injury. Scaffolds with ﬁbrin
can help to repair bone cavities, neurons, heart valves in the human
body [31,32]. Gelatin is a protein that helps to strengthen bones,
joints, ﬁngernails and hair qualities [33]. Poly(ethylene glycol)
(PEG) hydrogels provide excellent biocompatibility, because this
material can attach tomost proteins, cells and antibodies [29]. Most
common PEG hydrogels used for scaffold materials are poly-
ethylene (glycol) diacrylate (PEGDA), poly (ethylene glycol) meth-
acrylate/dimethacrylate (PEGDMA), poly (D, L)elactic acid-co-
glycolic acid. These hydrogels exhibit different transitional tem-
perature. Poloxamer is a copolymer soluble in aqueous, polar and
non-polar organic solvents [29]. The most common poloxamer for
3D printing is pluronic F127. This material is liquid at 4e5 C and
becomes a gel at room temperature (>16 C). Poly(2-hydroxyethyl
methacrylate)-pHEMA is a transparent polymer forming hydrogel
in water. Oxygen to diffuse through the layer, makes them a good
selection for bio-scaffolds [34].
Due to the ability to rapidly form a gel, the above hydrogels are
suitable candidates for scaffold supports in later cell cultures. Fig. 2
shows the schematic presentations of the bio-ink for hard and soft
bio materials. The next two sub-sections will discuss their
formulations.2.2.1. Bio-ink for hard materials
Bone marrow stromal cells (BMSCs), calcium phosphate (CaP),
tri-calcium phosphate (TCP), poly(lactic acid) (PLA), poly-glycolic
acid (PGA), poly-caprolactone (PCL) have been used to formulate
bio-ink for hard materials [35,38e42]. BMSCs is a source of sur-
rounding tissues with capability to migrate extensively in bone,
cartilage and fat. This material also results in muscle degeneration.
CaP has chemical similarity, biocompatibility and mechanical
strength of bone, offering a huge potential for its construction, and
repair. Over 70% of the bone is formed with CaP minerals. Another
unique property of CaP is the ability to absorb different chemical
species onto their surfaces [43]. Different compositions of CaP
provide beneﬁciaries for the formulation of the bone grafts and its
surroundings. TCP is one of the major components of bone mineral.
The crystalline polymorphs of alpha/beta TCP provides improved
compressive strength and better osteo conductivity. Hydroxyapa-
tite (HA) is another form of CaP that efﬁciently puriﬁes and sepa-
rates proteins, enzymes, nucleic acids, growth factors and other
macromolecules surrounding the bones [44]. Tetra calcium phos-
phate (TTCP) formed at temperature above 1300 C is used for self-
setting CaP bone cements [45]. Biphasic calcium phosphate (BCP) is
a mixture of HA, Ca and beta-TCP. This material is used in ortho-
paedic and dental applications for forming micro porous structures
with higher compressive strength, and better osteo conductivity
[46]. PLA, PGA and PCL are the most common synthetic biode-
gradable polymers for bone ﬁxations and cartilage repairs because
of their excellent biocompatibilities, biodegradability's and me-
chanical strength [47]. These synthetic polymers accelerate the
bone repair process without any sign of inﬂammation or foreign
body reactions [48].
Bio-ink used for hard biomaterials were utilized predominately
to construct strong connective tissue (i.e. bone). However, before
forming a bio-ink, essential parameters such as powder packing
density, ﬂow ability, wettability, drop volume needs to be opti-
mized [40]. Moreover, the printed bio-material should serve as
ample support for the embedded cells, e.g. stiff enough to allow
ﬁber arrangement whilst sustaining the force for handling and
implantation.
Fig. 2. Bio-inks for hard and soft materials (rearranged and redrawn from [35e37]).
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structions (natural bone) with CaP (hydroxyapatite, HA and beta
tricalcium phosphate, b-TCP) blended in calcium sulphate (CaSO4)
at different ratios [35]. Bergmann et al. fabricated a bone scaffolds
by utilizing b-TCP as a bone cement mixing with bio-active glasses
(45S5 Henchglass) [49]. Different combination of orthophosphoric
acid (H3PO4), pyrophosphoric acid (H7P2O7), isopropanol solution
mixed with the processed powder, formed the predesigned scaffold
structures. Inzana et al. implanted a 3D printed bone graft for tissue
engineering applications in a mouse model [50], and subsequently
proposed a number of steps to achieve a composite material of a-
TCP and HA from CaP powder solutions. Their acidic binder solu-
tions were prepared by dissolving collagen into phosphoric acid
and the two solutions produces dicalcium phosphate dehydrate
(DCPD) that was printed through a thermal ink jet printer.
Incorporating collagen in to CaP improved the overall bone
strength, the osteo conductive and the osteo inductive character-
istics, as well as the cellular attachments, viabilities, and prolifer-
ation of the cells. To observe the cell viability on the scaffolds, C3H/
10T1/2 cells were seeded onto the printed constructs, which
showed excellent biocompatibility and growth up to 72 h [50]. Kao
et al. formulated a number of bio-inkmaterials as functionalized 3D
printed scaffolds from poly(lactic acid) (PLA) [51]. However, the
hydrophobic nature of PLA resulted in less cell recognition. So
subsequently, polydopamine (PDA) surface coating was required to
improve cell adhesion, proliferation and differentiation. Human
adipose-derived stem cells (hADSCs) seeded on various fabricated
PDA coated PLA scaffolds displayed improved cell adhesion and
extracellular matrix (ECM) secretion. In conjunction with collagen,
Shim et al. encapsulated recombinant human bone morphogenetic
protein-2 (rhBMP-2) cells within collagen and gelatin solutions and
dispensed them into a hollow cylindrical type PCL/PLGA scaffolds
[52]. The combination of PCL/PLGA/collagen/rhBMP-2 showed a
better bone healing capability over PCL/PLGA/gelatin/rhBMP-2 in a
rabbit model. The 20-mm bone defects partially regenerated
through newly formed bone tissue, fused with the rabbits native
tissue after eight weeks post injury. Moreover, sufﬁcient incorpo-
ration of oxygen and nutrients are imperative for hard tissue such
as bone, in order to functionalize the printed structures and to
facilitate vascularization into the host tissue [53,54].2.2.2. Bio-ink for soft materials
Collagen, ﬁbrin and decellularized adipose tissue (DAT) were
used as ECM for soft materials bio-ink. Human mesenchymal stem
cells (hMSCs), SMCs, HeLa, hepatocarcinoma (HepG2), ﬁbroblasts,
ovary cells, keratinocytes, neural cells, BMSCs, chondrocytes,epithelial cells, ADSC, ovary cells, hepatocytes cells have all been
integrated into soft bio-materials [24,55e60]. Cui et al. developed a
bio-ink for repairing defects in bone-cartilage plugs by combining
human articular chondrocytes and PEG/DMAwith a photo-initiator
[61]. The printed construct produced excellent viabilities of almost
89.2%. Li et al. developed a bio-ink materials for constructing
vascular channels using a combination of gelatin/alginate/chitosan/
ﬁbrinogen hydrogels as the supporting materials and rat primary
hepatocytes (ADSCs) cells cross linked with thrombin, CaCl2,
Na5P3O10 and glutardialdehyde [62]. A combination of these
hydrogels and cross linkers can enhance the integrity of the
vascular channels for more than two weeks. Human livers can be
repaired or fabricated by seeding this ADSCs that performed liver
like metabolic functions.
Each of the cells used in bio-ink need a different preparation
process, so that they can retain their natural extracellular envi-
ronment. For example, for forming a bio-ink with adipose tissue,
decellularization is ﬁrst needed. To decellularize the adipose tissue
and achieve a high concentrated solution for printing, a number of
steps were initiated to completely remove the cell's nuclei from the
tissue for extrusion through the printing nozzles [63]. Decellular-
ized extracellular matrix (dECM) was one of the best options for
bio-ink material, as these cells can naturally obtain the microen-
vironment similar to their parent tissues. However, the challenge of
formulating the bio-ink is to minimize the cellular material while
keeping ECM loss and damage to a minimum. Pati et al. successful
decellularized adipose (adECM), cartilage (cdECM) and cardiac
muscle (hdECM) tissues utilizing physical, chemical and enzymatic
processes with 3D open porous structures. The decellularization
efﬁciency was quantiﬁed through DNA analysis, showing a 98%
reduction of cellular contents [37]. Furthermore, the authors suc-
cessfully printed these soft material structures up to a thickness of
10 layers. Song et al. used a hyaluronic acid-HA (an extra cellular
matrix protein) based hydrogel as the bio-ink. To form the gel, HA
was cross linked with poly(ethylene glycol) which can be used at a
later date as the base material for bio-printing [17]. De Maria et al.
trialled human skin ﬁbroblast at concentrations of 100,000 cells/ml
in the bio-ink, that is supported by Eagle's minimum essential
medium (EMEM). In this case, 360 drops or 50 ml (about 5000 cells)
were dispensed in a predesigned well, and the well was ﬁlled with
450 ml EMEM to avoid the impact of the droplets with the rigid
substrate [64].
Hydrogel materials pose excellent bio compatibility, bio-
degradability and tuneable mechanical properties, albeit their
high water content. Hydrogel materials are reported as an encap-
sulator for viable cells, as they can keep cells alive without affecting
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example, Duan et al. implemented a 3D bio-printing system to
fabricate an aortic valve conduits [65]. Aortic root sinus smooth
muscle cells (SMC) and aortic valve leaﬂet interstitial cells (VIC)
were separately encapsulated in an alginate/gelatin hydrogel so-
lution. These encapsulated cells were still viable within the
hydrogel encapsulator over a seven day culture (81.4 ± 3.4% for SMC
and 83.2 ± 4% for VIC). Lozano et al. constructed a 3D brain like
structures with bio-ink materials consisting of primary cortical
neurons encapsulated by gellan gum arginine-glycine-aspartate
(RGD-GG) which is a modiﬁed bio-polymer hydrogel [66]. To sta-
bilize the pH of the bio-ink, NaOHwas added afterwards. The study
of Lozano et al. suggested that the gellan gum (GG) is a good
encapsulationmaterial for neuronal cells with lowcost, high gelling
efﬁciency, and improved bio-compatibility [67]. Moreover, GG
modiﬁedwith RGD increases cell adhesion and proliferation. Chung
et al. utilized three different concentrations of sodium alginate
solutions in phosphate buffered saline (PBS) separately blended
with gelatin solutions [68]. The solution was ionically cross-linked
with CaCl2 and equilibrated in dulbecco's modiﬁed eagle medium
(DMEM)/fetal bovine serum (FBS) culture medium. Primary
myoblast (BL6) cells were cultured with appropriate media (Hams
F10, FBS, penicilin) and combined with the solution as an encap-
sulator. The prepared hydrogel-based bio-ink showed excellent cell
culture viability support and cell proliferative facilitation for pri-
mary muscle growth. Lee et al. fabricated a hybrid scaffold material
consisting of an acrylate trimethylene carbonate (TMC)/trimethy-
lolpropane (TMP) and alginate hydrogel solutions to encapsulate
chondrocyte cells. The seeded cells and the scaffolds structures
remained stable up to four weeks upon implanting into a mouse
model [69,70].
Miniature tissue spheroids can be incorporated into a bio-ink,
allowing uniform geometry that is necessary for cellecell in-
teractions [71,72]. Tissue spheroids are sphere shaped groups of
cells formed by spontaneous assembly within cellular suspensions.
Uniform sized tissue spheroids are essential for bio-printing large
tissues and organs. As tissue spheroids are formed by aggregation
of cells, they possess maximum possible cell density within each
spheroid. The average diameter of the tissue spheroids ranges from
100 to 300 mm [73]. Spheroids intrinsic capacity of being fused over
time, makes them an ideal candidate for forming bio-ink materials
[74].
Norotte et al. used Chinese hamster ovary (CHO) cells, human
umbilical vein smooth muscle cells (HUVSMCs), human skin ﬁ-
broblasts (HSFs) cells cultured in various ratios to form a desired
cell spheroids as a bio-ink materials to construct vascular tubes
[73]. The spheroids fused within 5e7 days resulting the ﬁnal
structure. However, a large quantity of spheroids for constructing
longer structure is time consuming and a long fusion time could
lead to a non-uniform hollow structures. Almost 4000 spheroids of
300 mmwere needed to construct a simple 10 cm long and 1.5 mm
diameter tube. Therefore, to form a large structure, rapid deposition
process and fast fusion of spheroids are necessary. This research
group also developed a bio-ink with similar cells (multicellular
cylinder as a bio-ink) dispensing continuously to form a cylindrical
shapes. The multicellular cylinders fused faster than the spheroids
structure, and needed only 2 eto 4 days to form the ﬁnal shapes.
However, the outer diameter of 900 mm (dispended with 300e500-
mm diameter micropipette) limits the cell viabilities. A smaller
micropipette could construct a narrower tube resulting in more
viable cells.
Recently Raja et al. exploited the ﬂoating liquid marble platform
to generate spheroids of olfactory ensheathing cells (OEC) [75].
5000 cells per 10 mL of marble generated numerous uniformed
spheroids (around 30 spheroids per marble) with an averagediameter of 90e120 mm. The OEC spheroids showed extensive
cellecell interactions indicating robust growth and healthy
behaviour over time. The ﬂoating marble on appropriate culturing
medium provided sufﬁcient nutrients for the cell spheroids to
survive. The group is expecting to utilize these OEC spheroids as a
3D printable bio-ink material to analyse spinal cord injury system
in in-vivo applications. It is possible to formulate enormous amount
of spheroids within a short period of time.
Furthermore, cells must be encapsulated in a non-adhesive and
lubricated hydrogel such as hyaluronan to prevent preliminary
tissue fusion inside the cellular suspension reservoir. Tan et al.
formed tissue spheroids by mixing ECs and SMCs (1:1 ratio) seeded
into non-adhesive agarose hydrogel moulds [76]. Approximately
840 uniformed cell spheroids with an average uniform diameter of
300 mm were prepared and printed. The cells can further be
encapsulated within other hydrogel material such as alginate,
collagen and cross linked with Ca2þ solutions to restrict their ag-
gregation and sedimentation. However, these encapsulating ap-
proaches are not suitable for all cell types, as some cell types
require a speciﬁc arrangement according to their phenotypic
functions [24]. For instance, Ferris et al. tested a consistent printing
output of cells without allowing for settling and aggregation, over
an extended time periods [77]. Ferris et al. formed a micro gel with
biopolymer gellam gum combined with DMEM, and/or poloxamer
188 surfactant in different concentrations. C2C12, PC12 and L929
cells were separately maintained in DMEM, FBS andmixed with the
microgel solution to form the bio-ink. The printed construct on
collagen hydrogel makes the cells hydrated and viable without
settling and aggregated for a long time period. Table 2 presents the
bio-ink materials with appropriate media/cross linkers conducted
by various groups.
It is important to ﬁnd out the nature of the extruded bio-inks.
For example, if the bio-ink is acidic in nature, it must ﬁrst be
adjusted to the physiological pH before encapsulation with cells,
whilst maintaining the desired temperature [37]. Rutz et al. pro-
posed a versatile method with various hydrogels that can tune the
mechanical, physical, chemical and biological properties of the bio-
ink [78]. Investigations were conducted to validate these formula-
tions for cell viabilities after printing with live/dead assays in PEGX-
gelatin and PEGX-ﬁbrinogen.2.3. Modiﬁcation of the print head
Depending on the deposition technique of the print head and
the bio-ink, bio-printers are categorized in three types: (i) ink jet,
(ii) laser jet and (iii) extrusion.
An ink-jet printer consists of an ink chamber with a number of
nozzles. A short current pulse passes through an integrated heating
element creating a bubble forcing the ink out of the nozzles [84]. A
piezoelectric actuator can also be used for this purpose. A voltage
pulse induces a charge on the piezoelectric material and ejects
droplets out of the nozzle [85]. The ink-jet technique offers ad-
vantages such as low cost and minimal contamination of the cells
due to the non-contact deposition technique. However, heat, me-
chanical stress and vibration could adversely affect the cell viability,
clog the nozzle and make it harder to construct a multi-layer 3D
structure [86].
Laser jet is the next deposition technique that utilizes the en-
ergy of a laser pulse to create the actuation bubble ejecting the cells
onto a substrate [55]. This technology can work with a high-
viscosity bio-inks such as hydrogel consisting of alginate and
collagen and provides a high degree of precision. However, the
relatively long printing time and the heat generated from the laser
lead to a higher rate of damaged cells [87].
Table 2
Bio-ink materials with appropriate media/cross linkers.
Printed
objects
Printing
technique
Bio-ink formation Media Implants Ref.
Scaffold Encapsulator Cells/Protein Cross linker
Hard
tissues
Thermal CaP:CaSO4, HA:CaSO4
and, b-TCP:CaSO4
e e Water based binders e In-vitro [35]
e b-TCP, bio-active glass
(45S5 Hench glass)
e e H3PO4, H7P2O7 e In-vitro [49]
Thermal CaP solutions with a-
TCP and HA
e C3H/10T1/2 Collagen, Acidic binder
(phosphoric acid)
e In-vitro/
In-vivo
[50]
e PLA coated with PDA e hADSCs e DMEM, FBS, penicillin,
streptomycin
In-vitro [51]
Extrusion PCL,PLGA Collagen, gelatin hTMSCs, rhBMP-
2
e DMEM, FBS In-vitro/
In-vivo
[52]
Thermal Chondrogenic
progenitor plugs (bio-
paper)
PEGDMA Human articular
chondrocytes
Photo initiator DMEM, Human serum,
penicillin, streptomycin,
glutamine
In-vitro [61]
Laser Titanium powder e Human
osteogenic
sarcoma (MG63)
Silica sol e In-vitro [79]
Soft
tissues
Extrusion e Agarose rods CHO, HUVSMCs,
HSFs, PASMCs
e DMEM, FBS, antibiotics
(penicillin, streptomycin,
gentamicin), Geneticin,
Hams F12, glutamine,
gelatin
In-vitro [73]
Extrusion Gelatin, alginate,
chitosan, ﬁbrinogen
Gelatin, alginate,
chitosan, ﬁbrinogen
Hepatocytes,
ADSCs
Thrombin, CaCl2, Na5P3O10
and glutaraldehyde
DMEM, FBS, penicillin,
streptomycin, aprotinin,
In-vitro [62]
Extrusion PCL DAT hASCs e DMEM, FBS, penicillin,
streptomycin
In-vivo [63]
Extrusion PCL adECM, cdECM,
hdECM
hASCs, hTMSCs e DMEM, aMEM, FBS,
antibiotics (penicillin,
streptomycin)
In-vitro [37]
Extrusion e RGD-GG Primary cortical
neural cells
DMEM or CaCl2 Collagenase, FBS,
neurobasal media,
glutamine, penicillin/
streptomycin
In-vitro [66]
Extrusion e Sodium alginate,
gelatin
Primary myoblast
(BL6)
CaCl2 DMEM, FBS, penicillin,
streptomycin, Hams F10,
glutamine
In-vitro [68]
Ink jet e Sodium alginate ECs and SMCs CaCl2, gelatin EGM-2 (Endothelial
growth medium)
In-vitro [76]
Piezo-Ink-jet Collagen bio-paper Gellam gum C2C12, PC12 and
L929
Poloxamer 188 (P188) and/
or ﬂuorinate
DMEM, FBS, HS (horse
serum)
In-vitro [77]
Extrusion e Gelatin, ﬁbrinogen,
4 arm PEG amine
HDFs, HUVECs PEGX-gelatin, PEGX-
ﬁbrinogen, EDC {N-(3-
Dimethylaminopropyl)-N-
ethylcarbodiimide}, NHS
(N-Hydroxysuccinimide),
thrombin
PBS (phosphate-buffered
saline) or DMEM, FBS,
antibiotics (penicillin,
streptomycin)
In-vitro [78]
Thermal Sodium alginate-
collagen composite
e hAFSCs, dSMCs,
bECs
CaCl2 MEM, DMEM, EBM-2,
clonetics, FBS, glutamine,
penicillin/streptomycin,
In-vitro/
In-vivo
[80]
Extrusion Gelatin
methacrylamide
Hydrogel solutions
(Bovine type B
gelatin)
HepG2 1-{4-(2-Hydroxyethoxy)-
phenyl}-2methyl-1-
propane-1-one, and 2,20-
Azobis{2-methyl-N-(2-
hydroxyethyl)
propionamide}
DMEM, FBS, penicillin
and streptomycin
In-vitro [81]
e e e HAFs and
HUVECs
e DMEM, penicillin/
streptomycin, EGM-2
In-vitro [82]
Extrusion PCL, alginate solution Sodium alginate Chondrocytes,
osteoblast
CaCl2, NaCl solutions DMEM/FBS/penicillin and
streptomycin.
In-vitro [83]
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lizes a pneumatic dispensing system for delivering the cells. This
technology suits a wide range of bio-ink viscosities and allows
continuous deposition, fast printing time and better structural
integrity [87]. Even though extrusion process is considered to be
the most adopted technique to date, the technology also faces
several limitations such as limited material selection due to rapid
cell encapsulation and increased shear stress resulting in more cell
injuries [86].
Fig. 3 illustrates the above-mentioned printing technologies.
Each of the printing technologies has their own advantages andlimitations. A suitable technology and the corresponding print head
must be considered based on the cell characteristic, resolution,
desired accuracy, number of deposition layers, structure of the
constructed tissue, printable size and overall printing time before
experimentation ensues.
A print head generally consists of a dispenser control unit, a
number of sensors, a set of reservoirs, biocompatible nozzles, and
supplementary components such as ﬁlter, hose tubes, camera and
curing light. The print head needs to be biocompatible allowing for
non-toxic delivery of bio-ink without exposing the cells to elevated
temperatures and pressures. Conventional print heads have ﬁxed
Fig. 3. Schematic diagram of (A) thermal ink-jet printers, (B) piezo-electric ink-jet printers, (C) extrusion printers, and (D) Laser printers.
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number of selective materials can be dispensed from these print
heads. For the purpose of bio-printing, the head needs to be
modiﬁed allowing multi-nozzle capabilities to dispense different
polymers, hydrogels or the combination of both, simultaneously
[8]. To date, researchers have always customized and modiﬁed the
print head according to their speciﬁc needs [88,89]. Thus, the print-
head operation may vary from continuous ﬂow to extrusion modes
to drop on demand (DOD)modes [64]. Print head clogging, reduced
cell viability, and DNA damage of cells are a few among many
challenges in designing and modifying a print head.
De Maria et al. modiﬁed a piezo-electric ink jet print head. The
ﬂow was controlled by an electronic board equipped with a micro-
controller (ATmega328P) [64]. Ang et al. utilized a print head con-
sisting of a robotic dispensing system and a pneumatic dispenser to
deliver chitosan at a variety of viscosities [90]. Moreover, the au-
thors used Teﬂon lined nozzle to prevent adhesion and accumula-
tion of cells around the nozzle tip. Pati et al. utilized six printing
heads and six holders to dispense cells and hydrogels simulta-
neously. Each of the print heads operated at a different tempera-
tures depending on the properties of the materials [63]. Norotte
et al. used two print heads to simultaneously deposit scaffolds in
the form of gels and multicellular mixture [73]. Coatney et al. used
three print heads to construct blood vessels and cardiac tissues.
Coatney et al. utilized the ﬁrst two print heads to dispense cardiac
and endothelial cells. The third print head dispenses collagen to
ensure support for the cell structure during the printing [91].
Dispensing bio-ink through a modiﬁed print head has to
consider the shear rate the cell will endure during the extrusion.
The average shear rate is the ratio between the speed of a droplet
(ms1) and its radius (m). Previous reports suggested that the
allowable shear rate for cell survival should be below 5  105 s1
[92]. Therefore, the expected shear rate has to be determined
before the printing process, and correlated with the viscosity of the
cells. A high shear force will damage the cells and thus reducing
their viability in the printed construction [37]. For instance, in sy-
ringe based bio-printing, dispensed cells will endure higher shear
force with small nozzle diameters. The movements of the print
head could expose the constructed cells to either compressive or
tensile forces. Chang et al. examined the effect of pressures and
varying nozzle sizes on viability, recovery, and functional behaviour
of HepG2 liver cells encapsulated by alginate [93]. The report
suggested that cell viability is proportional to nozzle diameter, and
inversely proportional to the applied pressure.
Commercially available one or two reservoir systems have been
reported incorporating a nozzle system with an average innerdiameter of 200 mme1600 mm. Reservoir material could be made of
aluminium, stainless steel, polyethylene or polypropylene coated
by bio compatible solutions [94]. Each reservoir can carry speciﬁc
scaffold or cell materials. These reservoirs could have a number of
sensors to synchronise the nozzles of the print head.
Selecting a right nozzle for printing biological cells is another
crucial design consideration for a print head. Conventional nozzles/
needle could be converted into biocompatible nozzles by coating
bio-compatible silicone to increase the hydrophobicity of the inner
and outer surfaces. The coating prevents ink adhesion within the
nozzle/needle [64]. Nozzle size also affects the printing speed. Song
et al. showed that printing speed linearly increases with reduced
needle diameters [17]. However, a small needle diameter would
result in a smaller printed pattern. So the right reservoir and nozzle
has to be selected depending on the characteristics of the cells and
the constructed tissues. The nozzle can be controlled to dispense
bio-ink droplets of different sizes.
Billiet et al. conducted an experiment with the nozzle shapes
(conical and cylindrical) on HepG2 cells. The results showed higher
cell viabilities using conical shaped nozzle compared to cylindrical
shape nozzles under low inlet pressures [81]. Moreover, cells
printed with a bigger nozzle diameter maintained a higher cell
survival rates of around 97% then smaller diameters. Yan and his
groups varied the process parameters such as applied pressure and
nozzle size affecting the cell viabilities [95]. They conducted a
computational ﬂuid dynamic (CFD) analysis based on shear stress
and exposure time in term of cell damage. Experiments were car-
ried out on cells (Rat adrenal medulla endothelial cells-RAMEC)
mixed with alginate solutions deposited on calcium chloride so-
lutions with different pressure and nozzles sizes. The experimental
data shows that cell damage increases with high pressure whereas
larger nozzle diameter minimizes it. Moreover, exposure time also
has an impact on cell viabilities. A combination of higher pressure,
and longer exposure time could lead to a higher cell damage.
Jones et al. examined the effects of nozzle length on cell via-
bilities. The result suggested that the short nozzle length (8.9 mm)
provides higher cell viabilities of almost 84% compared with the
long nozzle length (24.4 mm) with a cell viabilities of 71% [96]. As
long nozzle increases the dispensing time of cells subjected to face
shear forces throughout the nozzles, viability of the cells dramati-
cally reduces.
2.4. Computer aided design and manufacturing (CAD/CAM)
Asmentioned in the earlier section, the information of the sliced
layered design with individual cell types and sizes passes to the
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nizer or advance programming interface (API) synchronizer), the
motion control unit, and the reservoirs connected to the print head
work in a real time. The software passes signals requesting material
information from the sensor in the reservoirs. The designated
sensor then sends back the present status of the material of an
individual reservoir [15]. Subsequently, the controller sends a set of
commands to the individual reservoir to dispense the bio-ink
droplets considering the speciﬁc cell types, cell sizes and viscos-
ities. After dispensing the droplets containing the cells, feedback
information returns to the control unit. This unit has a
microcontroller-based motion control software that directs the
print head to a speciﬁc coordinate according to the pattern and
changes the reservoir and supplementary component if different
materials are needed [15]. Fig. 4 illustrates the representative
working steps of a hypothetic human organ transferring into a
printed model. Depending on the needs, more print heads associ-
ated with a set of reservoirs, nozzle systems, and sensors can be
appended.
For printing, heads containing multiple nozzle systems and a set
of microcontroller units synchronize the multiple nozzles with the
positioning system. The control software might be integrated with
the 3D positioning software or could work independently. How-
ever, the software must know the position and the type of material
to be deposited. In this regard, both the dispensing software and
the 3D positioning software need to be synchronized. Users should
be able to conﬁgure each nozzle depending on their need. For
example, Yan et al. designed a multi-nozzle deposition system
based on extrusion printing for fabricating scaffolds of bone tissue
structures [23]. Each of the nozzles played a different role for the
construction and the maintenance of the cells. The ﬁrst nozzle
(screw pump) deposited a composite of poly (L-latic acid), tri cal-
cium phosphate (TCP) to form bone tissue scaffolds. The second
nozzle (solenoid) dispensed de-ionized water as a supportive ma-
terial, and the third nozzle (ultra-sonic homogenizer) sprayed bone
morphogenic protein (BMP) particles with de-ionized water to re-
cruit stem cells from the surroundings.
The selection of the print head and the nozzle type depends on
the property of the bio-ink. For example, extrusion type print head
and nozzle with high dispensing pressure are suitable for bio-inksFig. 4. Representative working steps of a humawith high viscosity. For inks with medium viscosity, a screw pump
design can be selected to dispense cells with high viability. For ink
with low viscosity, a solenoid nozzle is preferable [23]. Saedan et al.
developed two types of nozzle systems: piezoelectric nozzle for
materials with low viscosity and low ﬂow rates, and the solenoid
nozzle for materials with relatively high viscosity [15]. Khalil et al.
constructed amultiple nozzle system for up to 40 layers of hydrogel
scaffold made of sodium alginate of various viscosities [98]. Each of
these nozzles has a different deposition technique. For example, a
current pulse activates solenoid nozzles. An applied voltage actu-
ates a piezoelectric nozzle made of a glass capillary. Pneumatic
syringe nozzles operate with a pressure pulse. A spray nozzle also
operates with a pressure pulse. These nozzles are also capable of
printing cells, growth factors and other scaffold materials.
To speed up the printing process, it is possible to use more than
one automated arm with multiple print heads. Ozbolat et al.
developed two independent and identical 3-axes bio-printers
called multi-armed bio-printer (MABP), capable of printing multi-
ple bio-inks simultaneously [99]. This deposition system operated
with stepper motors and linear actuators. The dispensing nozzle is
connected with a pneumatic ﬂuid dispenser. The deposition rate of
the bio-ink is controlled during the deposition process. Modiﬁed
ink jet printers with piezoelectric pumps have been reported for
assembling cells onto a 3D shape. The modiﬁed printers use indi-
vidual cell spheroids to form the 3D scaffolds [88,89]. The modiﬁed
ink jet printer works similar to the BAT system. They utilize a sy-
ringe and a needle tip capable of sterilizing separately. The print
head can bemodiﬁed to allowmultiple nozzles to work at the same
extrusion time to form cell patterns.
3. Recent applications of 3D bio-printing
The human body consists of more than 200 different and so-
phisticated cell types with their own biological, chemical, and
physical properties [100]. The main aim of bio-printing is achieving
printed functional cell and tissue systems towards organ printing.
To achieve this aim, researchers need to investigate the viability
and longevity of cells during and after the printing process. This
section will elaborate recent attempts of printing cells, tissues and
organs.n organ transferring into a printed model.
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The shape of the printed cell structures plays a signiﬁcant role
for its viability, legibility, and longevity. For example, dome shaped
structures show better stress distribution over cubic structures
[63]. The design should provide sufﬁcient transportation of nutri-
tion and oxygenwithin the tissue to keep the cell alive. Diffusion of
nutrition, oxygen and protein has limited depth dependency of
about a few hundred microns. To keep the cells and tissues alive,
the printed structures should have ample vascular space. For this
purpose, porosity between cells and cell layers is required to
facilitate cell viability and proliferation.
It is also important to select the right scaffold to prevent the cell
structures from collapsing and to support remodelling and repair. A
scaffold is a three dimensional porous substrate, where cells are
cultured to form living tissues. Generally, low-viscosity bio-inks are
dispensed onto a more viscous bio-substrate to produce the scaf-
fold. During the in-vitro experiments, desired cells are placed into
the biomaterial scaffolds to provide structural and logistic tem-
plates for tissue formation. Later the whole construction is cultured
in a bioreactor to promote continued cell growth prior to being
implanted into the host body to further mature and integrate.
However, as the constructed cells release their own ECM, the
scaffold biomaterial should fully degrade to form tissue like
structures that can subsequently integrate within the surrounding
host tissue upon implantation [101,102].
Conventional scaffold manufacturing techniques are ﬁber
bonding, solvent casting, particulate leaching, membrane lamina-
tion, and melt bonding [23]. To date, polycaprolactone (PCL) [103],
modiﬁed PCL with calcium phosphate [104], glycerol with soy
protein [105], PLC with alginate [83], collagen and gelatin [106]
have been reported as potential candidates for scaffold materials.
The major issues for forming a scaffold are balanced apoptosis, cell
proliferation, cell attachment, cell density, cell differentiation and
migration, as well as mechanical, biological and chemical trans-
duction to guide the constructed cells [8,73]. Moreover, depending
on the characteristics of the cells, the properties of the scaffolds
should vary including scaffolds porosity, elasticity, stiffness, and
anatomical shapes. For instance, a polycaprolactone (PCL) frame-
work as a base has been reported for tissues printing. Pati et al.
utilizes scaffold based PCL material to support Decellularized Adi-
pose Tissue (DAT) encapsulatedwith human adipose tissue-derived
mesenchymal stem cells (hASCs) as a bio-ink material to form ad-
ipose tissue construct [63]. The viability was evaluated in mice
showing positive tissue inﬁltration, remodelling and formation in
both top and middle layers between 1 and 14 days.
Shim et al. used PCL and two alginate solutions as a supporting
framework to construct a 3D porous structures with chondrocytes
and osteoblast cells utilizing a printer with six dispensing heads
[83]. The cells were encapsulated in sodium alginate, diluted with
DMEM and cross-linked by CaCl2, NaCl solutions. The dispensed
cells remained viable for at least seven days with a rate of
95.6 ± 1.8%. The PCL framework provides enhanced mechanical
stability whereas the encapsulated alginate solution allows suitable
environment for the cellular arrangements and prevent damage
from the printing pressures.
Xu et al. prepared multiple cell types such as human amniotic
ﬂuid-derived stem cells (hAFSCs), canine smooth muscle cells
(dSMCs), bovine aortic endothelial cells (bECS) separately mixed
with calcium chloride (CaCl2) cross linkers to print with a thermal
inkjet printer [80]. The multiple cell types were delivered onto an
alginate-collagen composite scaffold. The 3D pie shaped construc-
tions survived andmatured as functional tissues in mice over seven
days with a cell viability of almost 90%. Schurman et al. utilized
sodium alginate solution dispensed between polycaprolactone(PCL) strands crosslinked by CaCl2 solution to create a viable hybrid
construct [107]. Combination of alginate-PLC structures shows a
better mechanical property then alginate alone, PCL alone struc-
tures. C20A4 cells (cultured in DMEM, supplemented with FBS,
penicillin, and streptomycin) were embedded in sterilized alginate
solution as a bio-ink material and deposited on the hybrid struc-
tures. The printed cell shows a high cell viability of almost 80% just
after the printing.
Decellularized adipose tissue (DAT) and injectable DAT based
micro carriers allow for the formation of adipo-inductive substrate
for human adipose derived stem cells (ASCs). This adipo-inductive
substrate can act as scaffolds for adipose generation [108]. Stable
non-cross linked porous foam utilizing human DAT has been re-
ported as scaffolds for tissue engineering mimicking biochemical
and biomechanical properties of the native cell [109]. The paper
suggested advantages of the DAT foam based scaffold over the DAT
scaffold with higher angiogenic capacity, better cell migration and
suitable degradation. Work has been conducted on direct cartilage
repair using a 3D printed biomaterial scaffold. For instance, Cui
et al. modiﬁed a thermal inkjet printer and utilized a combination
of poly(ethylene glycol) dimethacrylate (PEGDMA) and human
chondrocytes to repair osteochondral plugs for cartilage [61].
Signiﬁcantly improved printing resolution was reported with cell
viabilities of 89.2 ± 3.6% for simultaneous photo polymerization.
Hydrogels such as alginate, collagen, chitosan, fabrin and syn-
thetic polymer such as pluronics, polyethylene glycol [86] has been
used as a 3D scaffolds for cell culturing, monitoring cellecell
interaction, and cell control for both soft and hard tissue re-
generations [110]. Their presence increases the cell seeding efﬁ-
ciency. Grifﬁth et al. introduced two DNA-based hydrogels for
forming a bio-degradable bio-ink, one consisting of polypeptide-
DNA and another of double stranded DNA (dsDNA). The inks
were extruded from a modiﬁed 3D printer [111]. Due to the bio-
degradability of the DNA bio-ink system, the rapid formation of a
3D constructs for temporary scaffolding in biomedical applications
was achieved.
Lee et al. developed a 3D printing method to construct a larger
ﬂuidic vascular channel (lumen size of around 1 mm) allowing an
adjacent capillary network through a natural maturation process
[112]. Collagen hydrogel was used as a main scaffold material and
gelatin as a sacriﬁcial material to create the channels. Fibrinogen,
thrombin, human umbilical vein endothelial cells (HUVECs),
normal human lung ﬁbroblasts (NHLFs) with a combination of
growth factors and culture medium were mixed and deposited
between the two vascular channels. HUVECs were seeded into the
channel to create the cell lining. Flowing media through the
channel shows robust interconnected vascular lumen up to few
weeks. Hydrogel bio-paper (ﬁbrin, matrigel, ﬁbrinogen, poly-
ethylene glycol tetra-acrylates) could also be used as a temporary
supports for the deposited bio-ink material for large tissue and
organ constructions [28]. Aria et al. uses a bio-paper with
hydrogel consisting of CaCl2, polyvinyl alcohol (PVA) and hya-
luronan for supporting the alginate based bio-ink material [113].
Boland et al. utilizes a thermos-sensitive gel (N-iso-
propylacryamide-co-2-(N,N-dimethylamino)-ethyl acrylate)
above 32 C to serve as a bio-paper for 3D construction of cells
[89]. This bio-paper could easily be removed after the fusion of
the printed cell spheroids.
The stiffness of the framework is sometimes greater than the
printed tissues and causes problems for future adjustment with the
native cells [63]. Themechanical properties of a scaffold should also
match with the native cells, and thus do not create any complica-
tions. Scaffold degradation, mechanical mismatch with native cells
causing immunogenicity, toxicity, and host inﬂammatory response
are the issues of using scaffold as printed tissue supports [73].
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normal activities of the constructed cells.
Many research groups also focused on fabrication techniques for
scaffold-free engineered tissues. In order to maintain a certain
shape, integrity and composition, the printed cell construct must
have a rapid tissue maturation process in the absence of solid
scaffolds. Some of the common advantages of this approach is the
absence of scaffold degradation, better intercellular communica-
tion due to similar host environment and more functional capa-
bility with host cells, high cell density, rapid tissue formation [114].
Scaffold-free vascular reconstruction in-vitro for smooth muscle
cells and ﬁbroblasts have been reported for layer-by-layer printing
on agarose rods [73]. Tan et al. proposed and developed an alginate
based fabrication process [76]. The group fabricated a ring shaped
structures with micro droplets of alginate solution (tissue spher-
oids consists of ECs and SMCs encapsulated by the alginate)
deposited onto an alginate hydrogel substrate. The analysis showed
a sufﬁcient amount of collagen-1 secretion from the construction
promoting cellecell adhesion, formation and maturations. Fig. 5
illustrates the different combination of scaffold-based and
scaffold-free approaches for constructing 3D bio-structures. Both
approaches need to maintain sufﬁcient waiting time to stabilize
each layer before constructing another new layer. Otherwise, the
whole structures may deform or collapse.
The scaffold-free approach also faces a number of challenges. For
instance, the fabrication process needs a large amount of spheroids
that consume much time affecting the subsequent fusion process.
Further problems are vascularization of thick tissue construct, and
precise positioning of various multiple cell types [8]. The reports
suggested thermoreversible, photosensitive moulding gels, stimuli
sensitive polymers for scaffold free solutions that reduce the
complexity to separate the gels, while a complicated vascular
structure needs to be printed [73,115]. As both scaffold-based (in-
direct printing) and scaffold-free (direct printing) approaches have
their own advantages and limitations, a hybrid method incorpo-
rating both approaches may solve the above challenges.Fig. 5. Tissue constructions with pores (A) continuous deposition of scaffolds materials wit
drop on demand deposition of scaffolds materials without cells; (E) with only cells, (F) com3.2. Tissue printing
One key construction process of cell structure is tissue fusion
[116]. Tissue fusion is a process where multiple tissues merge
together due to this surface tension forces and cell intergrowth.
Tissue fusion relies on self-organizing properties of cells that in
turn promote cell proliferation, cellecell and cell-ECM interactions.
Moreover, cell polarity is an important factor for the fusion process
allowing mutual adhesiveness of different cells to merge together.
Merging similar cell types is called homotypic cell fusion. Osteo-
clast e bone cells that maintain, repair and remodel bones e is an
example of homotypic cell fusions [117]. Merging different cell
types is called heterotypic cell fusion. Bone marrow derived den-
dritic cells (BMDCs) fused with neuron/glial cells of brain, or with
myocyte cells of the heart are an example of this heterotypic cell
fusion [118].
The printed cell structure may shrink or become shorter after a
certain time due to the fusion phenomena. This shrinking of mul-
tiple cells could deform the whole printed structures. Sufﬁcient
scaffold supports (scaffold based approaches) around the fused
cells or deposited hydrogel substrate (scaffold free approaches) can
prevent the undesired deformation. The fusion process also helps to
shape the structures while unwanted fusion stages are avoided. For
example, Thompson et al. chopped embryonic avian heart tubes
into myocardial rings, and then made them fuse and morph over-
night onto a synchronized heart tube for supporting a tubular
frameworks [119]. This process is due to the biological capacity
allowing closely positioned soft tissue fragments to fuse over time
[120]. Fig. 6 presents the formation of heterogeneous cell spheroids
from individual cells. Cell spheroids can be used as a potential bio-
ink material to construct multi-layer artery system. The printing
process fuses and forms the ﬁnal shapes. For a large volume of
tissue and organ printing, a fast fusion process might be needed.
Fast fusion can be achieved by reducing the distance between the
cells (high resolution) through shaking in a way that the printed
constructs do not deform [121,122].hout cells; (B) with only cells; (C) Combination of cells and scaffold materials; and (D)
bination of cells and scaffold materials.
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vascular system is a network of perfusable channel capable of
delivering oxygen, nutrients and removing waste solutions to
conﬁrm the viability and functionality of the printed construct. A
vascular system consists of a complex networks of blood vessels
with various lengths and diameters. The diameter ranges from
20 mm to 2.5 cm from very ﬁne capillaries to the aorta of the body
[123]. However, the inner part of the whole vascular system is
unique and is lined with a monolayer of ﬂat endothelial cells (ECs).
Without a vascular system, adequate perfusion of growth factors
(such as proteins or hormones), oxygen and nutrition is not feasible
leading to both normal and premature cell death [120]. Another
essential prerequisite for constructing vascular cells are to have
both deﬁned inlet and outlet branches to pass on these growth
factors, oxygen and nutrition.
Before printing a functional human organ such as lung or kid-
ney, a blue print of the vascular system has to be designed. For
printing the complex networks, developmental mechanism of the
vascular system has to be understood in details. For example, vas-
culogenesis (forming new micro vessels from non-endothelial
cells) [124,125], angiogenesis (forming new micro vessels from
endothelial cells) [125], and arteriogenesis (remodelling small
vessels into larger one) [126,127] are essential prerequisites to
create the intra-organ hierarchical vascular branched of different
diameters. Recent papers suggested that the printed vascular
segment undergoes on a retraction stages which results almost a
two folds reduction in its printed dimensions [128]. Therefore, the
designed blue print should be as twice of its ﬁnal sizes to achieve aFig. 6. Step by step construction of an arteryviable vascular tree. However, the compaction and the retraction
properties of tissues are different. A systematic research accounting
the predicted construct after the printing is necessary.
Researchers considered all of these issues for vascular vessel
printing. For example, Kucukgul et al. constructed an anatomically
correct macro vascular aorta from a real human aorta model [129].
To avoid compaction and retraction of the model, a computer-aided
algorithm was developed. The aorta was constructed utilizing pri-
mary mouse embryonic ﬁbroblast cells supported by a thermos-
responsive hydrogel named Novogel. The accuracy of the con-
structed cellular structures was around 91e95% with 97% for the
support materials. Hockaday et al. fabricated an anatomically ac-
curate, heterogeneous aortic valve of inner diameters ranging from
12 to 22 mm [130]. Porcine aortic valve interstitial cells (PAVIC)
were seeded with the PEG-DA hydrogel to formulate the con-
structions. Alginate-gelatin solution was used to support the con-
structed geometry of the overhanging ostia and leaﬂets. The
printed geometric accuracy (swelling affects) was quantiﬁed for
each layers with the micro-CT scan and compared with the corre-
sponding CAD STL ﬁles. The comparison indicates higher geometric
precision of almost 93% that reduced somewhat as inner diameter
of the valve decreases. The constructed valve swells outwards due
to the surface tensions indicating for printing of tinner wall to
match the target shapes. The printed aortic valve maintained near
100% of cell viably over 21 days.
Kelm et al. reported a scaffold-free concept to create blood
vessels of small diameter utilizing the self-assembly of human
artery-derived ﬁbroblasts (HAFs) and human umbilical veinwall for multi-cellular artery systems.
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required around 4000e5000micro tissues to fabricate a vessel of 5-
mm length, 3-mm diameter and 1-mm thickness of the wall [82].
Lee et al. developed a methodology to form a functional in-vitro
vascular channel (up to 5 mm distance and 5 million cells/mL
density) within thick collagen hydrogel scaffolds [131]. The
biomaterial includes HUVECs of different densities in 5% CO2 and
endothelial cell growth medium-2 (EGM-2). Gelatin was used as a
sacriﬁcial material to create the ﬂuidic channels. The process yields
a high cell viability of almost 90% in only two weeks. Nishiyama
et al. formed an alginate-based tubular structures into CaCl2 solu-
tion allowing an adjustable thickness from 30 to 40 mm and an
inner diameter from30 to 200 mm respectively by varying themicro
gel solution [132]. Xu et al. used an inkjet bio-printer to construct a
vertical vascular tube using hemi-branching points. They success-
fully formed a 5-mm long freestanding tube consisting of 210 layers
of Ca-alginate droplets [133]. However, alginate is not a good se-
lection for constructing a vascular network as it does not help cells
to grow and bond. Moreover, biodegradability of this material has
not yet been conﬁrmed by in-vivo applications. Therefore, more
research is needed for including alginate with other materials
allowing native ECM like behaviours [134].
Norotte et al. reported a scaffold-free approach using agarose
rods to construct a multi-layer vascular tube using human uterine
smooth muscle cells (HUSMC) and human skin ﬁbroblast (HSF)
cells. These printed tubes are similar to vessels in microvasculature
with diameters ranging from 0.9 to 2.5 mm. The fused construc-
tions are sufﬁciently stable to handle and to transfer into a specif-
ically designed bio-reactor for further maturation and for
implantation [73]. Li et al. constructed a vertical hollow channel
without scaffold support using various combinations of alginate/
gelatin/chitosan/ﬁbrinogen hydrogel as a printed materials [62].
A double-layer sturdy tube could also be made with HUVSMCs
and human dermal ﬁbroblast (HDFs) capable of transferring
directly onto a bio-reactor for further maturation [135]. Miller et al.
introduced rapid casting of a vascular channel based on carbohy-
drates with a mixture of glucose, sucrose, dextran forming self-
supporting lattices. The diameter of the vascular channel ranges
between 150 and 750 mm, coated and encapsulated by poly(lactid-
co-glycolid) (PLGA) and living cells of ﬁbrin/agarose/matrigel/
poly(ethylene glycol) (PEG), respectively [136]. Engelhardt et al.
conducted a free-form construction of a tubular system with di-
ameters ranging from 10 mm to 100 mm with synthetic polymer-
protein microstructures. Due to the hydrophobic nature of the
material in an aqueous environment, the vascular network retains
its shape and mechanical properties allowing a higher elasticity
[137].
Sometimes, the printed cells cannot survive even with ample
supply of proteins, oxygen and nutrition. A new technique needed
to be developed to increase the life span of the printed cells. For
example, Wu et al. utilized laser assisted printing technology to
construct human umbilical vein endothelial cells (HUVECs) on a
branch/stem structure. The printed structures fused and connected
with each other within one day, but could not survive longer [138].
Introducing an extra layer of human umbilical vein smoothmuscles
cells (HUVSMCs) on HUVECs dramatically increases the longevity of
the constructed blood vessels. It is likely that the HUVEC and
HUVSMC have the symbiotic relationship allowing proliferative
state and higher viabilities. The constructed branch remains intact
after 9 days of deposition. Campos et al. fabricated high-aspect-
ratio hollow tubes using a syringe-based deposition of agarose
hydrogel encapsulating human mesenchymal stem cells (hMSCs)
and human MG-63 cells [139]. The construction was submerged in
a hydrophobic high-density ﬂuid named perﬂuorotributylamine
(C12F27N) promoting mechanical supports and higher cellproliferations. This ﬂuid reduces the surface tension, increases the
contact angel of each droplets (from 55 of air to almost 70 into the
ﬂuid). Fabrication of complex and large volume of vascular tree
without a supporting scaffold is achievable with this approach.
Moreover, the ﬂuorocarbon allows sufﬁcient oxygen and carbon
dioxide diffusion that keeps the cell alive for a long printing time.
The printed cells were viable up to 21 days from deposition.
However, once printing is done, the ﬂuid needs to be replaced with
cell culture medium. This process could deform the complex
printed structures. Moreover, printing speed and resolution need a
major improvement.
3.3. Organ printing
One of the biggest issues of human organ transplantation is the
limited number of donors compared to the number of patients.
Sometimes, infection and rejection of the organ causes suffering
and often death [140]. The ultimate aim of bio-printing technology
is the rapid design and fabrication of operational human tissues and
organs to replace those damaged, injured or lost. Moreover, the
organ of a living body needs a network of vessels and capillaries to
provide sufﬁcient oxygen, cytokines, nutrients, as well as to remove
the toxic waste from them.
For this purpose, all constructed cells need to be interconnected
and placed close to the capillary network to receive enough oxygen
and nutrients. For example, kidney vascular tree consists of 10e12
branches incorporating around 10,000 of segments. If the re-
searchers can successfully design and fabricate functional, long and
viable blood vessels, organ printing of for example lung or kidney
will become close to the reality. As tissue engineering is still in its
early stage, fabricating a whole operational organ needs to solve a
number of current challenges such as printing speed, resolution,
biocompatibility, cell viability, cytotoxicity, and gentle fusion.
Tissues utilize organizational capacity and chemical signals from
cells to build a speciﬁc structure leading to the organ formation by
copying the natural morphogenesis. For example, ECs will form
tubular like structures on their own due to the genetically pre-
destined form, if a suitable external environment is provided.
Supplying sufﬁcient media incorporating nutrients, oxygen, and
proteins can create suitable environment. A bioreactor can provide
this environment, the structural and functional maturation of the
printed organ/tissues [141]. Iwsaki et al. developed a pulsatile
bioreactor that regulates pressures, ﬂow circulations, heart rates,
concentration of carbon di-oxide and pH of an engineered in-vitro
blood vessels. The group fabricated a three-layer robust and elastic
artery system from polyglycolic acid (PGA) seeded with smooth
muscle cells (SMCs), PCL seeded with SMCs, and PGA seeded with
ﬁbroblasts. The whole construct was wrapped around a silicon
tubing [142]. After removing the supportive tube, the lumen was
seeded with ECs and was mounted with the bioreactors. The result
shows a similar appearance, strength and elasticity of a native ar-
tery. As the fabrication process was conventional, the results can be
acknowledged to formulate a more complex 3D printed vascular
systems and functional organs with similar pulsative bioreactors.
3D bio-printing has been utilized in urologic applications
particularly for bladder replacements [143,144]. The process in-
volves the collection of tissues from the bladder and cells prolif-
eration outside the body. The fabricated bladder scaffold was then
covered with the harvested cells that can be later implanted. Atala
et al. successfully fabricated a whole human bladder of three
distinctive layers with modiﬁed ink-jet bio-printing technologies
[145,146]. The bladder scaffolds were fabricated from collagen or a
composite of collagen and polyglycolic acid (PGA) [147,148]. The
smoothmuscle cells (SMCs) collected from individual patients were
seeded on the exterior surface of the biodegradable bladder shaped
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seeded by coating the urothelial cells. Finally the whole construc-
tion were wrapped with omental during the implantations for
enhance vascularization of ﬂaps and grafts. The printed bladder
was transplanted on different patients with end-stage bladder
disease requiring cystoplasty. The engineered bladder showed long
term functionality with no major complications. Moreover, report
suggested silk ﬁbroin as a promising bio-material over collagen-
PGA scaffolds that has been tested on mice bladder constructions
[149]. However, before the clinical reality of the bladder re-
constructions, a number of improved trials with more legitimate
functional and durable steps are needed to be validated for these
experimental approaches.
Fig. 7 shows the representative construction of a human lung
system. A number of robotic arms each incorporating number of
reservoir's with heterogeneous bio-ink are needed to print the
whole functional lung systems. The multiple robotic arms build the
desired trachea, bronchus, bronchi and bronchioles system with
diverse tissue spheroids integral to the organ. The organ tissues can
be created from vascularized organo-speciﬁc tissue spheroids. Post
processing stages are essential to keep the organ fully functional
before implanting in the host body. For printing awhole organwith
multiple cell types, bio-plotting technology (printing the construct
into a less viscous solution by utilizing buoyancy compensation
principle) could perhaps be a good options to reduce the surface
tension and the gravitational force of large printed structures
[94,127]. The printed structure of this method has a smooth surface,
which is not suitable for cell adhesions and cellecell interactions. A
surface treatment could solve these problems. Moreover, several
challenges such as accuracy, resolution, limited range of scaffold
materials, processing speeds, and cell encapsulation, all of which
need to be addressed and improved in order to print a large
structures.
High cell density obviously allows for quick tissue assembly and
cell maturation, suitable for organ printing. For example, to fabri-
cate a human kidney, over one million glomeruli and nephrons are
needed which seems practically not feasible with current tech-
nologies [8]. Self-assembly and self-organisation, which are
autonomous processes of cells to form from an initial state to a ﬁnal
pattern, could make this complex fabrication process moreFig. 7. Demonstration of organ printing from multi-layer complex bronchi system of a lun
incorporating multiple robotic dispensing systems with number of reservoir and nozzles. Spractical. An example of these two phenomena are the histogenesis
and organogenesis of cells leading to a cellecell, and cell-ECM in-
teractions, which help to form the ﬁnal shapes of the tissues [135].
Ultimately, appropriate and feasible approaches considering the
self-assembly and self-organizing ability of human tissue spheroids
could make organ printing possible [150].
Rezende et al. suggested the fabrication of a non-adhesive
mould placed 1250 wells containing 5000 tissue spheroids of
each in order to fabricate a human kidney. The process needs ﬁve
robotic dispensing systems (each consists of 250 multi wells) to
handle the whole printing process [74]. Although their suggestion
remained an idea, it is not impossible to achieve this target with an
advanced technology. Computer aided design (CAD) and a blue
print of the particular organ are essential before initiating the
printing attempts. Digitized image reconstruction, magnetic reso-
nance imaging (MRI), computed tomography, and mathematical
modelling using theoretical principle will enable the detailed 3D
reconstruction of organs [120,151]. It is also essential to know in
advance, the structural determinants of material properties at
different stages of development for tissues and organs.
A more efﬁcient approach is the separation of the complicated
organ printing task into many simpler tasks that can be done
independently at the same time. The result can later be eventually
combined to produce a functioning organ ready for transplantation.
For example, mapping a human organ, converting it to a suitable 3D
design, slicing a 3D design into layer of 2D format for dispensing,
modifying the coordinate system, synchronizing the dispenser with
the software, could be done by engineering experts. Chemistry
experts could provide ample nutrition to the printed construct
using heterogeneous bio-ink. Medical experts can transplant the
desired organ into an in-vivo subject.
For organ printing, researchers may consider technological
challenges and solutions associated with the organ transplantation
process. Organ transplantation can be done by decellularization
and recellularization of cells. Decellularization is the process to
isolate the extra cellular matrix (ECM) of a tissue from its cellular
components. The decellularization process retains the structural,
and functional characteristic of the original micro-vascular network
and prepares the scaffold for tissue engineering. This scaffold
product also maintains the protein, and growth factor of naturalg to whole printed lung. The printing process can be initiated from bottom-up setup
acriﬁcial scaffolds are used to hold the structures if necessary.
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organs such as heart, liver, bladder, artery, skin and trachea
[152e154]. Similar initiatives can be addressed for preparing
functional bio-ink metrics allowing for printing the whole organ.
In contrast, recellularization allows the vascular network to be
connected for the circulation, facilitation of rapid oxygen and nu-
trients with the host for cell viabilities, and cell functions [152].
During the recellularization process, functional organ can be
reproduced by introducing progenitor or adult stem cells within the
scaffolds. This knowledge may be useful after successful printing of
a whole organ, maintaining its functional properties with bio-
reactors facilitating the transplantation. Furthermore, a detailed
analytical approach of cell formations and cell interactions might
allow to form a set of universal bio-ink material suitable for
commercialization. For example, human induced pluripotent stem
cells (hiPSCs), human embryonic stem cells (hESCs) have been re-
ported to be present in varieties of tissues and organs. Combination
of these cells with a suitable hydrogel solution could make a ver-
satile bio-ink for constructing a number of engineered tissues and
organs. These cells have excellent ability to self-renew for indeﬁnite
times, and pluripotency e the capability of forming any type of
adult cells or tissues by mimicking the early stages of embryo-
genesis. Moreover, human pluripotent stem cell shows similar
physiological reaction of a whole organ in a smaller scale. Utilizing
this stem cell line for fabricating micro tissues and organs will
promote more reliable drug testing platform and an end of animal
testing.
Jones et al. used hESCs derived hepatocyte like cells with algi-
nate hydrogel matrix as a bio-ink material to construct a circular
structure of 40 layers inside of a multi well plates [96]. The con-
structed structures maintained their pluripotency and showed
excellent viabilities, and proliferation for longer periods. Ouyang
et al. used extrusion-based 3D printing to fabricate ESCs into a 3D
cell-laden structures [155]. ESCs weremixed with a matrix material
of gelatin/alginate hydrogel solution and printed into a layer-by-
layer cubic porous structures. Cell viabilities were more than 90%
promoting pluripotency and proliferation. The cell proliferation
allows the ESCs to form highly uniformed and size controllable
spheroids. However, it takes longer time (5 days) to reach the same
size spheroids diameter of 60e70 mm. Producing human tissues
from pluripotent stem cells requires a lengthy culture period of
several weeks to months. Therefore it is very important to ensure
the printed construct to be free from microbial contaminations.
Maintaining a high-class microbiological safety cabinet and an
improved sterility system is necessary.
4. Perspectives and conclusions
Bio-printing technology still is in its infant stage. In terms of
both technology and biology, a number of challenges still have to be
solved. For instance, engineering challenges are the development of
a fast printing process, the improvement of nozzle and cartridge
design, improving resolutions, avoiding clogging problem for large
size organ printing, suitable stress and temperature condition
without effecting cell viabilities. A major challenge is to write a
control script for computers to identify individual cells by their
visual characteristics and to print them accordingly. Moreover, the
scripts need to be modiﬁed for printing different types of organ for
an individual patients. In terms of biology, bio-compatibility, cell
viability, cytotoxicity, fusion without deformation, leak-free
perfusion, high cell density, printed cell transformation to the
host are major issues to be solved.
Various research groups have reported 3D printing of cell con-
structs. However, fabricating a full operational and long-life cell
structure will be a greater challenge. A successful attempt will leadto the construction of the whole human organ. For these purposes,
current medical knowledge associated with organ transplantation
needs to be integrated with future 3D organ-printing platform.
Engineers, biologists, chemists, computer scientists, mathemati-
cians and physicians need to work together to solve the challenges
of the bio-printing. Biologists need to address what is needed to be
understood and to be developed. Based on the feedback of bi-
ologists, engineers design the printing platforms considering
mathematical parameters and physical laws. Computer scientists
develop corresponding software to synchronize the machines with
the speciﬁc needs of users. A cell data bank needs to be established
that will include cell properties and behaviours so that the bi-
ologists can use, further modify and improve them if needed. This
cell database will facilitate the future commercialisation of 3D or-
gan printing. Moreover, commercialisation of bio-printing requires
large-scale bio-fabrication tools. Barnett et al. recently conducted
an experiment with large-scale 3D printing where the robotic tools
with six degrees of freedom allowing a large range of motion. Even
though their printing material was non biological as they utilized
polymeric foam to construct a large-scale statue, the knowledge
and challenges from this can be taken in consideration for the
future large-scale bio-printing [18].
It will be possible for surgeons to facsimile patient's speciﬁc
body parts according to the needs for repair, replace or removed.
Considering the state of the art of bio-printing, it might take two or
three decades or perhaps more to fabricate a marketable printed
human organs with high order of functionality. Nonetheless within
the next decade, direct visualization and quantiﬁcation of diverse
medical and biological processes can be expected. For example,
artiﬁcial skin printing (in-vitro) as a testing beds for cosmetic in-
dustries; engineered tissues and mini organ printing for toxicity/
efﬁciency screening of pharmacological drugs; in-vitro tumour,
cancer, trauma, and infected tissue modelling that might enables
examination of identical operational conditions in human body.
Customized 3D printing for dental industries, urological applica-
tions, bone vascular co-culture for orthopaedic applications, stem
cell based neurological applications, personalized medicine will
become increasingly a common practice.
The 3D printing of a speciﬁc tissue such as tumour for drug
testing will improve the efﬁciency of the drug. Preclinical testing
including in-vitro analysis to determine toxicity, absorption, dis-
tribution and metabolism on the cells and tissues will enhance
the reliability of the drug. Three-dimensional bio-printing tech-
nology will hopefully one day solve the organ transplantation
crisis and revolutionize health sectors including drug screening,
tissue engineering, and biological testing with minimum clinical
trials.References
[1] E.L. Eisenstein, The Printing Press as an Agent of Change, Cambridge Uni-
versity Press, 1980.
[2] N.D. Hopkinson, Emerging rapid manufacturing processes, in: Rapid
Manufacturing; An Industrial Revolution for the Digital Age, Wiley & Sons
Ltd, Chichester, 2006. W. Sussex.
[3] N. Grujovic, M. Radovic, V. Kanjevac, J. Borota, G. Grujovic, D. Divac, 3D
printing technology in education environment, in: 34th International Con-
ference on Production Engineering, 2011, pp. 29e30.
[4] C.W. Hull, Apparatus for Production of Three-dimensional Objects by Ster-
eolithography USA, 1986.
[5] S.M. Oliveira, R.L. Reis, J.F. Mano, Towards the design of 3D multiscale
instructive tissue engineering constructs: current approaches and trends,
Biotech. Adv. 33 (6) (2015) 842e855.
[6] S.V. Murphy, A. Atala, 3D bioprinting of tissues and organs, Nat. Biotechnol.
32 (2014) 773e785.
[7] V. Mironov, V. Kasyanov, R.R. Markwald, Organ printing: from bioprinter to
organ biofabrication line, Curr. Opin. Biotech. 22 (2011) 667e673.
A. Munaz et al. / Journal of Science: Advanced Materials and Devices 1 (2016) 1e17 15[8] V. Mironov, R.P. Visconti, V. Kasyanov, G. Forgacs, C.J. Drake, R.R. Markwald,
Organ printing: tissue spheroids as building blocks, Biomaterials 30 (2009)
2164e2174.
[9] E. Malone, H. Lipson, Fab@ Home: the personal desktop fabricator kit, Rapid
Prototyp. J. 13 (2007) 245e255.
[10] C.M. Smith, A.L. Stone, R.L. Parkhill, R.L. Stewart, M.W. Simpkins,
A.M. Kachurin, W.L. Warren, S.K. Williams, Three-dimensional bioassembly
tool for generating viable tissue-engineered constructs, Tissue Eng. 10 (2004)
1566e1576.
[11] J. Straub, S. Kerlin, Development of a large, low-cost, instant 3d scanner,
Technologies 2 (2014) 76e95.
[12] L. Galantucci, E. Piperi, F. Lavecchia, A. Zhavo, Semi-automatic low cost 3D
laser scanning systems for reverse engineering, Proc. CIRP 28 (2015) 94e99.
[13] W. Sun, B. Starly, J. Nam, A. Darling, Bio-CAD modeling and its applications in
computer-aided tissue engineering, Comput. AidedDes. 37 (2005)1097e1114.
[14] A. Pﬁster, R. Landers, A. Laib, U. Hübner, R. Schmelzeisen, R. Mülhaupt,
Biofunctional rapid prototyping for tissue-engineering applications: 3D
bioplotting versus 3D printing, J. Polym. Sci. Part A Polym. Chem. 42 (2004)
624e638.
[15] L. Li, M. Saedan, W. Feng, J. Fuh, Y. Wong, H. Loh, S. Thian, S. Thoroddsen,
L. Lu, Development of a multi-nozzle drop-on-demand system for multi-
material dispensing, J. Mater. Process. Technol. 209 (2009) 4444e4448.
[16] C. Kucukgul, B. Ozler, H.E. Karakas, D. Gozuacik, B. Koc, 3D hybrid bioprinting
of macrovascular structures, Proc. Eng. 59 (2013) 183e192.
[17] S.J. Song, J. Choi, Y.D. Park, J.J. Lee, S.Y. Hong, K. Sun, A three-dimensional
bioprinting system for use with a hydrogel-based biomaterial and printing
parameter characterization, Artif. Organs. 34 (2010) 1044e1048.
[18] E. Barnett, C. Gosselin, Large-scale 3D printing with a cable-suspended robot,
Addit. Manuf. 7 (2015) 27e44.
[19] D.L. Cohen, E. Malone, H. Lipson, L.J. Bonassar, Direct freeform fabrication of
seeded hydrogels in arbitrary geometries, Tissue Eng. 12 (2006) 1325e1335.
[20] W.E. Müller, E. Tolba, H.C. Schr€oder, B. Diehl-Seifert, T. Link, X. Wang, Bio-
silica-loaded poly (є-caprolactone) nanoﬁbers mats provide a morphoge-
netically active surface scaffold for the growth and mineralization of the
osteoclast-related SaOS-2 cells, Biotechnol. J. 9 (2014) 1312e1321.
[21] E. Barnett, J. Angeles, D. Pasini, P. Sijpkes, Surface mapping feedback for
robot-assisted rapid prototyping, robotics and automation (ICRA), in: 2011
IEEE International Conference on, IEEE, 2011, pp. 3739e3744.
[22] S. Keating, N. Oxman, Compound fabrication: a multi-functional robotic
platform for digital design and fabrication, Robot. Comput. Int. Manuf. 29
(2013) 439e448.
[23] Y. Yan, Z. Xiong, Y. Hu, S. Wang, R. Zhang, C. Zhang, Layered manufacturing of
tissue engineering scaffolds via multi-nozzle deposition, Mater. Lett. 57
(2003) 2623e2628.
[24] S. Wüst, R. Müller, S. Hofmann, Controlled positioning of cells in biomaterials
e approaches towards 3D tissue printing, J. Func. Biomater. 2 (2011)
119e154.
[25] R. Landers, A. Pﬁster, U. Hübner, H. John, R. Schmelzeisen, R. Mülhaupt,
Fabrication of soft tissue engineering scaffolds by means of rapid prototyping
techniques, J. Mater. Sci. 37 (2002) 3107e3116.
[26] M. Charnley, M. Textor, A. Khademhosseini, M.P. Lutolf, Integration column:
microwell arrays for mammalian cell culture, Integr. Biol. 1 (2009) 625e634.
[27] M. Gruene, M. Pﬂaum, A. Deiwick, L. Koch, S. Schlie, C. Unger, M. Wilhelmi,
A. Haverich, B. Chichkov, Adipogenic differentiation of laser-printed 3D tis-
sue grafts consisting of human adipose-derived stem cells, Biofabrication 3
(2011) 015005.
[28] T. Billiet, M. Vandenhaute, J. Schelfhout, S. Van Vlierberghe, P. Dubruel,
A review of trends and limitations in hydrogel-rapid prototyping for tissue
engineering, Biomaterials 33 (2012) 6020e6041.
[29] K. Turksen, Bioprinting in Regenerative Medicine, Springer, 2015.
[30] P. Serwer, Agarose gels: properties and use for electrophoresis, Electropho-
resis 4 (1983) 375e382.
[31] D. Bartis, J. Pongracz, Three Dimensional Tissue Cultures and Tissue Engi-
neering, University of Pecs, Hungary, 2011. Retrieved from Digitalis
Tankonyvtar.
[32] L.A. Evans, K.H. Ferguson, J.P. Foley, T.A. Rozanski, A.F. Morey, Fibrin sealant
for the management of genitourinary injuries, ﬁstulas and surgical compli-
cations, J. Urol. 169 (2003) 1360e1362.
[33] E. Pulieri, V. Chiono, G. Ciardelli, G. Vozzi, A. Ahluwalia, C. Domenici, F. Vozzi,
P. Giusti, Chitosan/gelatin blends for biomedical applications, J. Biomed. Mat.
Res. Part A 86 (2008) 311e322.
[34] F. Liu, X. Zhou, F. Cui, D. Jia, Synthesis and properties of poly (hydroxyethyl
methacrylate) hydrogel for IOL materials, J. Biomed. Eng. 24 (2007) 595e598.
[35] Z. Zhou, F. Buchanan, C. Mitchell, N. Dunne, Printability of calcium phos-
phate: calcium sulfate powders for the application of tissue engineered bone
scaffolds using the 3D printing technique, Mater. Sci. Eng. C 38 (2014) 1e10.
[36] C. Mota, D. Puppi, F. Chiellini, E. Chiellini, Additive manufacturing techniques
for the production of tissue engineering constructs, J. Tissue Eng. Regen.
Med. 9 (2015) 174e190.
[37] F. Pati, J. Jang, D.-H. Ha, S.W. Kim, J.-W. Rhie, J.-H. Shim, D.-H. Kim, D.-W. Cho,
Printing three-dimensional tissue analogues with decellularized extracel-
lular matrix bioink, Nat. Comm. 5 (2014).
[38] R. Detsch, S. Schaefer, U. Deisinger, G. Ziegler, H. Seitz, B. Leukers, In vitro-
osteoclastic activity studies on surfaces of 3D printed calcium phosphate
scaffolds, J. Biomater. Appl. 26 (2010) 359e380.[39] P.H. Warnke, H. Seitz, F. Warnke, S.T. Becker, S. Sivananthan, E. Sherry, Q. Liu,
J. Wiltfang, T. Douglas, Ceramic scaffolds produced by computer-assisted 3D
printing and sintering: characterization and biocompatibility investigations,
J. Biomed. Mat. Res. Part B Appl. Biomater. 93 (2010) 212e217.
[40] S. Bose, S. Vahabzadeh, A. Bandyopadhyay, Bone tissue engineering using 3D
printing, Mater. Today 16 (2013) 496e504.
[41] J. Suwanprateeb, F. Thammarakcharoen, V. Wongsuvan, W. Chokevivat,
Development of porous powder printed high density polyethylene for
personalized bone implants, J. Porous Mater. 19 (2012) 623e632.
[42] G.A. Fielding, A. Bandyopadhyay, S. Bose, Effects of silica and zinc oxide
doping on mechanical and biological properties of 3D printed tricalcium
phosphate tissue engineering scaffolds, Dent. Mater. 28 (2012) 113e122.
[43] M.-P. Ginebra, T. Traykova, J. Planell, Calcium phosphate cements as bone
drug delivery systems: a review, J Control. Release 113 (2006) 102e110.
[44] A. Tiselius, S. Hjerten, €O. Levin, Protein chromatography on calcium phos-
phate columns, Arch. Biochem. Biophys. 65 (1956) 132e155.
[45] C. Moseke, U. Gbureck, Tetracalcium phosphate: synthesis, properties and
biomedical applications, Acta Biomater. 6 (2010) 3815e3823.
[46] R. LeGeros, S. Lin, R. Rohanizadeh, D. Mijares, J. LeGeros, Biphasic calcium
phosphate bioceramics: preparation, properties and applications, J. Mater.
Sci. Mater. Med. 14 (2003) 201e209.
[47] M.S. Lopes, A. Jardini, R. Maciel Filho, Poly (lactic acid) production for tissue
engineering applications, Procedia Eng. 42 (2012) 1402e1413.
[48] S. Vainionp€a€a, Biodegradation of polyglycolic acid in bone tissue: an
experimental study on rabbits, Arch. Orthop. Trauma. Surg. 104 (1986)
333e338.
[49] C. Bergmann, M. Lindner, W. Zhang, K. Koczur, A. Kirsten, R. Telle, H. Fischer,
3D printing of bone substitute implants using calcium phosphate and
bioactive glasses, J. Eur. Ceram. Soc. 30 (2010) 2563e2567.
[50] J.A. Inzana, D. Olvera, S.M. Fuller, J.P. Kelly, O.A. Graeve, E.M. Schwarz,
S.L. Kates, H.A. Awad, 3D printing of composite calcium phosphate and
collagen scaffolds for bone regeneration, Biomaterials 35 (2014)
4026e4034.
[51] C.-T. Kao, C.-C. Lin, Y.-W. Chen, C.-H. Yeh, H.-Y. Fang, M.-Y. Shie, Poly
(dopamine) coating of 3D printed poly (lactic acid) scaffolds for bone tissue
engineering, Mater. Sci. Eng. C 56 (2015) 165e173.
[52] J.-H. Shim, S.E. Kim, J.Y. Park, J. Kundu, S.W. Kim, S.S. Kang, D.-W. Cho, Three-
dimensional printing of rhBMP-2-loaded scaffolds with long-term delivery
for enhanced bone regeneration in a rabbit diaphyseal defect, Tissue Eng.
Part A 20 (2014) 1980e1992.
[53] N.E. Fedorovich, J. Alblas, W.E. Hennink, F.C. €Oner, W.J. Dhert, Organ printing:
the future of bone regeneration? Trends Biotechnol. 29 (2011) 601e606.
[54] D.H. Kempen, L. Lu, A. Heijink, T.E. Hefferan, L.B. Creemers, A. Maran,
M.J. Yaszemski, W.J. Dhert, Effect of local sequential VEGF and BMP-2 de-
livery on ectopic and orthotopic bone regeneration, Biomaterials 30 (2009)
2816e2825.
[55] L. Koch, S. Kuhn, H. Sorg, M. Gruene, S. Schlie, R. Gaebel, B. Polchow,
K. Reimers, S. Stoelting, N. Ma, Laser printing of skin cells and human stem
cells, Tissue Eng. Part C Methods 16 (2009) 847e854.
[56] X. Cui, T. Boland, D.D. D'Lima, M.K. Lotz, Thermal inkjet printing in tissue
engineering and regenerative medicine, Recent Pat. Drug Deliv. Formul. 6
(2012) 149.
[57] S. Moon, S.K. Hasan, Y.S. Song, F. Xu, H.O. Keles, F. Manzur, S. Mikkilineni,
J.W. Hong, J. Nagatomi, E. Haeggstrom, Layer by layer three-dimensional
tissue epitaxy by cell-laden hydrogel droplets, Tissue Eng. Part C. Methods
16 (2009) 157e166.
[58] A. Skardal, J. Zhang, G.D. Prestwich, Bioprinting vessel-like constructs using
hyaluronan hydrogels crosslinked with tetrahedral polyethylene glycol tet-
racrylates, Biomaterials 31 (2010) 6173e6181.
[59] A. Skardal, J. Zhang, L. McCoard, X. Xu, S. Oottamasathien, G.D. Prestwich,
Photocrosslinkable hyaluronan-gelatin hydrogels for two-step bioprinting,
Tissue Eng. Part A 16 (2010) 2675e2685.
[60] K. Iwami, T. Noda, K. Ishida, K. Morishima, M. Nakamura, N. Umeda, Bio rapid
prototyping by extruding/aspirating/reﬁlling thermoreversible hydrogel,
Biofabrication 2 (2010) 014108.
[61] X. Cui, K. Breitenkamp, M. Finn, M. Lotz, D.D. D'Lima, Direct human cartilage
repair using three-dimensional bioprinting technology, Tissue Eng. Part A 18
(2012) 1304e1312.
[62] S. Li, Z. Xiong, X. Wang, Y. Yan, H. Liu, R. Zhang, Direct fabrication of a hybrid
cell/hydrogel construct by a double-nozzle assembling technology, J. Bioact.
Compat. Polym. 24 (2009) 249e265.
[63] F. Pati, D.-H. Ha, J. Jang, H.H. Han, J.-W. Rhie, D.-W. Cho, Biomimetic 3D tissue
printing for soft tissue regeneration, Biomaterials 62 (2015) 164e175.
[64] C. De Maria, L. Ferrari, F. Montemurro, F. Vozzi, I. Guerrazzi, T. Boland,
G. Vozzi, Design and validation of an open-hardware print-head for bio-
printing application, Procedia Eng. 110 (2015) 98e105.
[65] B. Duan, L.A. Hockaday, K.H. Kang, J.T. Butcher, 3D bioprinting of heteroge-
neous aortic valve conduits with alginate/gelatin hydrogels, J. Biomed. Mat.
Res. Part A 101 (2013) 1255e1264.
[66] R. Lozano, L. Stevens, B.C. Thompson, K.J. Gilmore, R. Gorkin, E.M. Stewart,
M. In Het Panhuis, M. Romero-Ortega, G.G. Wallace, 3D printing of layered
brain-like structures using peptide modiﬁed gellan gum substrates, Bio-
materials 67 (2015) 264e273.
[67] C.J. Ferris, K.J. Gilmore, G.G. Wallace, Modiﬁed gellan gum hydrogels for
tissue engineering applications, Soft Matter 9 (2013) 3705e3711.
A. Munaz et al. / Journal of Science: Advanced Materials and Devices 1 (2016) 1e1716[68] J.H. Chung, S. Naﬁcy, Z. Yue, R. Kapsa, A. Quigley, S.E. Moulton, G.G. Wallace,
Bio-ink properties and printability for extrusion printing living cells, Bio-
mater. Sci. 1 (2013) 763e773.
[69] S.-J. Lee, J.-W. Rhie, D.-W. Cho, Development of three-dimensional alginate
encapsulated chondrocyte hybrid scaffold using microstereolithography,
J. Manuf. Sci. Eng. 130 (2008) 021007.
[70] S.-J. Lee, T. Kang, J.-W. Rhie, D.-W. Cho, Development of three-dimensional
hybrid scaffold using chondrocyte-encapsulated alginate hydrogel, Sens.
Mater. 19 (2007) 445e451.
[71] K.E. Kasza, A.C. Rowat, J. Liu, T.E. Angelini, C.P. Brangwynne, G.H. Koenderink,
D.A. Weitz, The cell as a material, Curr. Opin. Cell Biol. 19 (2007) 101e107.
[72] G. Forgacs, R.A. Foty, Y. Shafrir, M.S. Steinberg, Viscoelastic properties of
living embryonic tissues: a quantitative study, Biophys. J. 74 (1998)
2227e2234.
[73] C. Norotte, F.S. Marga, L.E. Niklason, G. Forgacs, Scaffold-free vascular tissue
engineering using bioprinting, Biomaterials 30 (2009) 5910e5917.
[74] R. Rezende, F. Pereira, V. Kasyanov, D. Kemmoku, I. Maia, J. Da Silva,
V. Mironov, Scalable biofabrication of tissue spheroids for organ printing,
Procedia CIRP 5 (2013) 276e281.
[75] R.K. Vadivelu, C.H. Ooi, R.-Q. Yao, J.T. Velasquez, E. Pastrana, J. Diaz-Nido,
F. Lim, J.A. Ekberg, N.-T. Nguyen, J.A. St John, Generation of three-
dimensional multiple spheroid model of olfactory ensheathing cells using
ﬂoating liquid marbles, Sci. Rep. 5 (2015) 15083.
[76] Y. Tan, D.J. Richards, T.C. Trusk, R.P. Visconti, M.J. Yost, M.S. Kindy, C.J. Drake,
W.S. Argraves, R.R. Markwald, Y. Mei, 3D printing facilitated scaffold-free
tissue unit fabrication, Biofabrication 6 (2014) 024111.
[77] C.J. Ferris, K.J. Gilmore, S. Beirne, D. McCallum, G.G. Wallace, Bio-ink for on-
demand printing of living cells, Biomater. Sci. 1 (2013) 224e230.
[78] A.L. Rutz, K.E. Hyland, A.E. Jakus, W.R. Burghardt, R.N. Shah, A Multimaterial
bioink method for 3D printing tunable, cell-compatible hydrogels, Adv.
Mater. 27 (2015) 1607e1614.
[79] F.-H. Liu, R.-T. Lee, W.-H. Lin, Y.-S. Liao, Selective laser sintering of bio-metal
scaffold, Procedia CIRP 5 (2013) 83e87.
[80] T. Xu, W. Zhao, J.-M. Zhu, M.Z. Albanna, J.J. Yoo, A. Atala, Complex hetero-
geneous tissue constructs containing multiple cell types prepared by inkjet
printing technology, Biomaterials 34 (2013) 130e139.
[81] T. Billiet, E. Gevaert, T. De Schryver, M. Cornelissen, P. Dubruel, The 3D
printing of gelatin methacrylamide cell-laden tissue-engineered constructs
with high cell viability, Biomaterials 35 (2014) 49e62.
[82] J.M. Kelm, V. Lorber, J.G. Snedeker, D. Schmidt, A. Broggini-Tenzer,
M. Weisstanner, B. Odermatt, A. Mol, G. Zünd, S.P. Hoerstrup, A novel
concept for scaffold-free vessel tissue engineering: self-assembly of micro-
tissue building blocks, J. Biotechnol. 148 (2010) 46e55.
[83] J.-H. Shim, J.-S. Lee, J.Y. Kim, D.-W. Cho, Bioprinting of a mechanically
enhanced three-dimensional dual cell-laden construct for osteochondral
tissue engineering using a multi-head tissue/organ building system,
J. Micromech. Microeng. 22 (2012) 085014.
[84] H.P. Le, Progress and trends in ink-jet printing technology, J. Imaging Sci.
Technol. 42 (1998) 49e62.
[85] J.C. Stachowiak, D.L. Richmond, T.H. Li, F. Brochard-Wyart, D.A. Fletcher,
Inkjet formation of unilamellar lipid vesicles for cell-like encapsulation, Lab
Chip 9 (2009) 2003e2009.
[86] A.B. Dababneh, I.T. Ozbolat, Bioprinting technology: a current state-of-the-
art review, J. Manuf. Sci. Eng. 136 (2014) 061016.
[87] I.T. Ozbolat, Y. Yu, Bioprinting toward organ fabrication: challenges and
future trends, Biomed. Eng IEEE Trans. 60 (2013) 691e699.
[88] W.C. Wilson, T. Boland, Cell and organ printing 1: protein and cell printers,
Anat. Rec. Part A Discov. Mol. Cell. Evol. Biol. 272 (2003) 491e496.
[89] T. Boland, V. Mironov, A. Gutowska, E. Roth, R.R. Markwald, Cell and organ
printing 2: fusion of cell aggregates in three-dimensional gels, Anat. Rec. Part
A Discov. Mol. Cell. Evol. Biol. 272 (2003) 497e502.
[90] T.H Ang, F.S.A Sultana, D.W Hutmacher, Y.S Wong, J.Y.H Fuh, X.M Mo,
H.T Loh, Burdet E, S.H Teoh, Fabrication of 3D chitosanehydroxyapatite
scaffolds using a robotic dispensing system, Mater, Sci. and Eng.: C. 20 (2002)
35e42.
[91] S. Coatney, B. Gandhi, B.S. Park, D. Dzilno, E.M. Tapia, G. Kamarthy, I. Sidhu,
3D Bio-printing, Fung Ins. For Eng. Lead, University of California at Berkeley,
2013.
[92] E.Q. Li, E.K. Tan, S.T. Thoroddsen, Piezoelectric Drop-on-demand Inkjet
Printing of Rat Fibroblast Cells: Survivability Study and Pattern Printing,
2013 arXiv preprint arXiv:1310.0656.
[93] R. Chang, J. Nam, W. Sun, Effects of dispensing pressure and nozzle diameter
on cell survival from solid freeform fabrication-based direct cell writing,
Tissue Eng. Part A 14 (2008) 41e48.
[94] R. Landers, R. Mülhaupt, Desktop manufacturing of complex objects, pro-
totypes and biomedical scaffolds by means of computer-assisted design
combined with computer-guided 3D plotting of polymers and reactive
oligomers, Macromol. Mat. Eng. 282 (2000) 17e21.
[95] K.C. Yan, K. Paluch, K. Nair, W. Sun, Effects of process parameters on cell
damage in a 3d cell printing process, in: ASME 2009 International Me-
chanical Engineering Congress and Exposition, American Society of Me-
chanical Engineers, 2009, pp. 75e81.
[96] A. Faulkner-Jones, C. Fyfe, D.-J. Cornelissen, J. Gardner, J. King, A. Courtney,
W. Shu, Bioprinting of human pluripotent stem cells and their directeddifferentiation into hepatocyte-like cells for the generation of mini-livers in
3D, Biofabrication 7 (2015) 044102.
[97] T.D. Goddard, T.E. Ferrin, Visualization software for molecular assemblies,
Curr. Opin. Struct. Biol. 17 (2007) 587e595.
[98] S. Khalil, J. Nam, W. Sun, Multi-nozzle deposition for construction of 3D
biopolymer tissue scaffolds, Rapid Prototyp. J. 11 (2005) 9e17.
[99] I.T. Ozbolat, H. Chen, Y. Yu, Development of ‘Multi-arm Bioprinter’ for hybrid
biofabrication of tissue engineering constructs, Robot. Comput. Int. Manuf.
30 (2014) 295e304.
[100] Q. Gu, J. Hao, Y. Lu, L. Wang, G.G. Wallace, Q. Zhou, Three-dimensional bio-
printing, Sci. China Life Sci. 58 (2015) 411e419.
[101] S.G. Priya, H. Jungvid, A. Kumar, Skin tissue engineering for tissue repair and
regeneration, Tissue Eng. Part B Rev. 14 (2008) 105e118.
[102] K. Lee, C.K. Chan, N. Patil, S.B. Goodman, Cell therapy for bone regeneration e
bench to bedside, J. Biomed. Mater. Res. Part B Appl. Biomater. 89 (2009)
252e263.
[103] W. Yeong, N. Sudarmadji, H. Yu, C. Chua, K. Leong, S. Venkatraman,
Y. Boey, L. Tan, Porous polycaprolactone scaffold for cardiac tissue engi-
neering fabricated by selective laser sintering, Acta Biomater. 6 (2010)
2028e2034.
[104] J.-T. Schantz, A. Brandwood, D.W. Hutmacher, H.L. Khor, K. Bittner, Osteo-
genic differentiation of mesenchymal progenitor cells in computer designed
ﬁbrin-polymer-ceramic scaffolds manufactured by fused deposition
modeling, J. Mater. Sci. Mater. Med. 16 (2005) 807e819.
[105] K.B. Chien, E. Makridakis, R.N. Shah, Three-dimensional printing of soy
protein scaffolds for tissue regeneration, Tissue Eng. Part C Methods 19
(2012) 417e426.
[106] W. Lee, V. Lee, S. Polio, P. Keegan, J.H. Lee, K. Fischer, J.K. Park, S.S. Yoo, On-
demand three-dimensional freeform fabrication of multi-layered hydrogel
scaffold with ﬂuidic channels, Biotechnol. Bioeng. 105 (2010) 1178e1186.
[107] W. Schuurman, V. Khristov, M. Pot, P. Van Weeren, W. Dhert, J. Malda, Bio-
printing of hybrid tissue constructs with tailorable mechanical properties,
Biofabrication 3 (2011) 021001.
[108] A.E. Turner, C. Yu, J. Bianco, J.F. Watkins, L.E. Flynn, The performance of
decellularized adipose tissue microcarriers as an inductive substrate for
human adipose-derived stem cells, Biomaterials 33 (2012) 4490e4499.
[109] C. Yu, J. Bianco, C. Brown, L. Fuetterer, J.F. Watkins, A. Samani, L.E. Flynn,
Porous decellularized adipose tissue foams for soft tissue regeneration,
Biomaterials 34 (2013) 3290e3302.
[110] M. Stanton, J. Samitier, S. Sanchez, Bioprinting of 3D hydrogels, Lab Chip 15
(2015) 3111e3115.
[111] L.G. Grifﬁth, G. Naughton, Tissue engineeringecurrent challenges and
expanding opportunities, Science 295 (2002) 1009e1014.
[112] V.K. Lee, A.M. Lanzi, H. Ngo, S.-S. Yoo, P.A. Vincent, G. Dai, Generation of
multi-scale vascular network system within 3D hydrogel using 3D bio-
printing technology, Cell. Mol. Bioeng. 7 (2014) 460e472.
[113] K. Arai, S. Iwanaga, H. Toda, C. Genci, Y. Nishiyama, M. Nakamura, Three-
dimensional inkjet biofabrication based on designed images, Biofabrication 3
(2011) 034113.
[114] B. Derby, Printing and prototyping of tissues and scaffolds, Science 338
(2012) 921e926.
[115] V.L. Tsang, A.A. Chen, L.M. Cho, K.D. Jadin, R.L. Sah, S. DeLong, J.L. West,
S.N. Bhatia, Fabrication of 3D hepatic tissues by additive photopatterning of
cellular hydrogels, FASEB J. 21 (2007) 790e801.
[116] J.M. Perez-Pomares, R.A. Foty, Tissue fusion and cell sorting in embryonic
development and disease: biomedical implications, Bioessays 28 (2006)
809e821.
[117] P.J. Nijweide, E.H. Burger, J.H. Feyen, Cells of bone: proliferation, differenti-
ation, and hormonal regulation, Physiol. Rev. 66 (1986) 855e886.
[118] B.M. Ogle, M. Cascalho, J.L. Platt, Biological implications of cell fusion, Nat.
Rev. Mol. Cell. Biol. 6 (2005) 567e575.
[119] R.P. Thompson, M. Reckova, A. de Almeida, M.R. Bigelow, C.P. Stanley,
J.B. Spruill, T.T. Trusk, D. Sedmera, The Oldest, Toughest Cells in the Heart,
Development of the Cardiac Conduction System: Novartis Foundation
Symposium 250, Wiley Online Library, 2003, pp. 157e176.
[120] V. Mironov, T. Boland, T. Trusk, G. Forgacs, R.R. Markwald, Organ printing:
computer-aided jet-based 3D tissue engineering, Trends Biotechnol. 21
(2003) 157e161.
[121] S. Katayama, S. Maeda, Y. Hara, S. Hashimoto, A self-assembling method for
polymer gel components, robotics and biomimetics (ROBIO), in: 2013 IEEE
International Conference on, IEEE, 2013, pp. 79e84.
[122] F. Xu, T.D. Finley, M. Turkaydin, Y. Sung, U.A. Gurkan, A.S. Yavuz,
R.O. Guldiken, U. Demirci, The assembly of cell-encapsulating microscale
hydrogels using acoustic waves, Biomaterials 32 (2011) 7847e7855.
[123] B. Schmitt, J. Ringe, T. H€aupl, M. Notter, R. Manz, G.R. Burmester, M. Sittinger,
C. Kaps, BMP2 initiates chondrogenic lineage development of adult human
mesenchymal stem cells in high-density culture, Differentiation 71 (2003)
567e577.
[124] S. Patan, Vasculogenesis and angiogenesis as mechanisms of vascular
network formation, growth and remodeling, J. Neuro-oncol. 50 (2000) 1e15.
[125] W. Risau, Mechanisms of angiogenesis, Nature 386 (1997) 671e674.
[126] M. Heil, I. Eitenmüller, T. Schmitz-Rixen, W. Schaper, Arteriogenesis versus
angiogenesis: similarities and differences, J. Cell. Mol. Med. 10 (2006)
45e55.
A. Munaz et al. / Journal of Science: Advanced Materials and Devices 1 (2016) 1e17 17[127] R.P. Visconti, V. Kasyanov, C. Gentile, J. Zhang, R.R. Markwald, V. Mironov,
Towards organ printing: engineering an intra-organ branched vascular tree,
Expert Opin. Biol. Ther. 10 (2010) 409e420.
[128] V. Mironov, J. Zhang, C. Gentile, K. Brakke, T. Trusk, K. Jakab, G. Forgacs,
V. Kasyanov, R. Visconti, R. Markwald, Designer ‘blueprint’ for vascular trees:
morphology evolution of vascular tissue constructs, Virtual Phys. Prototyp. 4
(2009) 63e74.
[129] C. Kucukgul, S.B. Ozler, I. Inci, E. Karakas, S. Irmak, D. Gozuacik, A. Taralp,
B. Koc, 3D bioprinting of biomimetic aortic vascular constructs with self-
supporting cells, Biotechnol. Bioeng. 112 (2015) 811e821.
[130] L. Hockaday, K. Kang, N. Colangelo, P. Cheung, B. Duan, E. Malone, J. Wu,
L. Girardi, L. Bonassar, H. Lipson, Rapid 3D printing of anatomically accurate
and mechanically heterogeneous aortic valve hydrogel scaffolds, Bio-
fabrication 4 (2012) 035005.
[131] V.K. Lee, D.Y. Kim, H. Ngo, Y. Lee, L. Seo, S.-S. Yoo, P.A. Vincent, G. Dai,
Creating perfused functional vascular channels using 3D bio-printing tech-
nology, Biomaterials 35 (2014) 8092e8102.
[132] Y. Nishiyama, C. Henmi, S. Iwanaga, H. Nakagawa, K. Yamaguchi, K. Akita,
S. Mochizuki, K. Takiura, M. Nakamura, Ink jet three-dimensional digital
fabrication for biological tissue manufacturing: analysis of alginate microgel
beads produced by ink jet droplets for three dimensional tissue fabrication,
J. Imaging Sci. Technol. 52 (2008), 60201-60201-60201-60206.
[133] C. Xu, W. Chai, Y. Huang, R.R. Markwald, Scaffold-free inkjet printing of
three-dimensional zigzag cellular tubes, Biotechnol. Bioeng. 109 (2012)
3152e3160.
[134] E. Hoch, G.E. Tovar, K. Borchers, Bioprinting of artiﬁcial blood vessels: current
approaches towards a demanding goal, Eur. J. Cardio Thorac. Surg. 46 (2014)
767e778.
[135] K. Jakab, C. Norotte, F. Marga, K. Murphy, G. Vunjak-Novakovic, G. Forgacs,
Tissue engineering by self-assembly and bio-printing of living cells, Bio-
fabrication 2 (2010) 022001.
[136] J.S. Miller, K.R. Stevens, M.T. Yang, B.M. Baker, D.-H.T. Nguyen, D.M. Cohen,
E. Toro, A.A. Chen, P.A. Galie, X. Yu, Rapid casting of patterned vascular
networks for perfusable engineered three-dimensional tissues, Nat. Mater.
11 (2012) 768e774.
[137] S. Engelhardt, E. Hoch, K. Borchers, W. Meyer, H. Krüger, G.E. Tovar,
A. Gillner, Fabrication of 2D protein microstructures and 3D polymer-
eprotein hybrid microstructures by two-photon polymerization, Bio-
fabrication 3 (2011) 025003.
[138] P. Wu, B. Ringeisen, Development of human umbilical vein endothelial cell
(HUVEC) and human umbilical vein smooth muscle cell (HUVSMC) branch/
stem structures on hydrogel layers via biological laser printing (BioLP),
Biofabrication 2 (2010) 014111.
[139] D.F.D. Campos, A. Blaeser, M. Weber, J. J€akel, S. Neuss, W. Jahnen-Dechent,
H. Fischer, Three-dimensional printing of stem cell-laden hydrogels sub-
merged in a hydrophobic high-density ﬂuid, Biofabrication 5 (2013) 015003.[140] T. Desmet, E. Schacht, P. Dubruel, Rapid prototyping as an elegant production
tool for polymerictissue engineering scaffolds, Tissue Eng. Roles Mater. Appl.
(2008) 141.
[141] S.-S. Yoo, 3D-printed biological organs: medical potential and patenting
opportunity, Expert Opin. Ther. Pat. 25 (2015) 507e511.
[142] K. Iwasaki, K. Kojima, S. Kodama, A.C. Paz, M. Chambers, M. Umezu,
C.A. Vacanti, Bioengineered three-layered robust and elastic artery using
hemodynamically-equivalent pulsatile bioreactor, Circulation 118 (2008)
S52eS57.
[143] Y. Soliman, A.H. Feibus, N. Baum, 3D printing and its urologic applications,
Rev. Urol. 17 (2015) 20.
[144] R.F. Youssef, K. Spradling, R. Yoon, B. Dolan, J. Chamberlin, Z. Okhunov,
R. Clayman, J. Landman, Applications of three-dimensional printing tech-
nology in urologic practice, BJU Int. 116 (5) (2015) 697e702.
[145] C.M. O'Brien, B. Holmes, S. Faucett, L.G. Zhang, Three-dimensional printing of
nanomaterial scaffolds for complex tissue regeneration, Tissue Eng. Part B
Rev. 21 (2014) 103e114.
[146] A. Atala, S.B. Bauer, S. Soker, J.J. Yoo, A.B. Retik, Tissue-engineered autologous
bladders for patients needing cystoplasty, Lancet 367 (2006) 1241e1246.
[147] A. Atala, Tissue engineering of human bladder, Br. Med. Bull. 97 (2011)
81e104.
[148] M. Horst, S. Madduri, R. Gobet, T. Sulser, V. Milleret, H. Hall, A. Atala,
D. Eberli, Engineering functional bladder tissues, J. Tissue Eng. Regen. Med. 7
(2013) 515e522.
[149] J.R. Mauney, G.M. Cannon, M.L. Lovett, E.M. Gong, D. Di Vizio, P. Gomez,
D.L. Kaplan, R.M. Adam, C.R. Estrada, Evaluation of gel spun silk-based bio-
materials in a murine model of bladder augmentation, Biomaterials 32
(2011) 808e818.
[150] Y. Lin, A. B€oker, J. He, K. Sill, H. Xiang, C. Abetz, X. Li, J. Wang, T. Emrick,
S. Long, Self-directed self-assembly of nanoparticle/copolymer mixtures,
Nature 434 (2005) 55e59.
[151] R. Karch, F. Neumann, M. Neumann, W. Schreiner, A three-dimensional
model for arterial tree representation, generated by constrained constructive
optimization, Comput. Biol. Med. 29 (1999) 19e38.
[152] B.E. Uygun, A. Soto-Gutierrez, H. Yagi, M.-L. Izamis, M.A. Guzzardi,
C. Shulman, J. Milwid, N. Kobayashi, A. Tilles, F. Berthiaume, Organ reen-
gineering through development of a transplantable recellularized liver graft
using decellularized liver matrix, Nat. Med. 16 (2010) 814e820.
[153] J.J. Yoo, J. Meng, F. Oberpenning, A. Atala, Bladder augmentation using
allogenic bladder submucosa seeded with cells, Urology 51 (1998) 221e225.
[154] H.C. Ott, T.S. Matthiesen, S.-K. Goh, L.D. Black, S.M. Kren, T.I. Netoff,
D.A. Taylor, Perfusion-decellularized matrix: using nature's platform to en-
gineer a bioartiﬁcial heart, Nat. Med. 14 (2008) 213e221.
[155] L. Ouyang, R. Yao, S. Mao, X. Chen, J. Na, W. Sun, Three-dimensional bio-
printing of embryonic stem cells directs highly uniform embryoid body
formation, Biofabrication 7 (2015) 044101.
